JP2009509961A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009509961A5 JP2009509961A5 JP2008532430A JP2008532430A JP2009509961A5 JP 2009509961 A5 JP2009509961 A5 JP 2009509961A5 JP 2008532430 A JP2008532430 A JP 2008532430A JP 2008532430 A JP2008532430 A JP 2008532430A JP 2009509961 A5 JP2009509961 A5 JP 2009509961A5
- Authority
- JP
- Japan
- Prior art keywords
- aminocyclohexyl
- trans
- imidazo
- pyridazine
- diamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims description 5
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims 66
- 125000001072 heteroaryl group Chemical group 0.000 claims 38
- 229910052739 hydrogen Inorganic materials 0.000 claims 34
- 125000003118 aryl group Chemical group 0.000 claims 30
- 239000001257 hydrogen Substances 0.000 claims 30
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 29
- 125000000753 cycloalkyl group Chemical group 0.000 claims 29
- 229910052757 nitrogen Inorganic materials 0.000 claims 24
- 125000003342 alkenyl group Chemical group 0.000 claims 23
- 229910052736 halogen Inorganic materials 0.000 claims 20
- 150000002367 halogens Chemical group 0.000 claims 20
- 150000002431 hydrogen Chemical group 0.000 claims 20
- 150000001875 compounds Chemical class 0.000 claims 19
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 18
- 125000005017 substituted alkenyl group Chemical group 0.000 claims 18
- 125000000547 substituted alkyl group Chemical group 0.000 claims 18
- 150000003839 salts Chemical class 0.000 claims 16
- 125000000304 alkynyl group Chemical group 0.000 claims 15
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 15
- 125000004426 substituted alkynyl group Chemical group 0.000 claims 15
- 125000004093 cyano group Chemical group *C#N 0.000 claims 13
- -1 heterocyclo Chemical group 0.000 claims 12
- 125000006413 ring segment Chemical group 0.000 claims 12
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 11
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 10
- 201000010099 disease Diseases 0.000 claims 9
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 7
- ZWBFLQKNWXAVDT-UHFFFAOYSA-N imidazo[1,2-b]pyridazine-6,8-diamine Chemical compound N1=C(N)C=C(N)C2=NC=CN21 ZWBFLQKNWXAVDT-UHFFFAOYSA-N 0.000 claims 7
- 125000004076 pyridyl group Chemical group 0.000 claims 7
- 125000003545 alkoxy group Chemical group 0.000 claims 6
- 125000002947 alkylene group Chemical group 0.000 claims 6
- 125000003386 piperidinyl group Chemical group 0.000 claims 6
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 5
- 125000002541 furyl group Chemical group 0.000 claims 4
- 125000004193 piperazinyl group Chemical group 0.000 claims 4
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 4
- 206010009900 Colitis ulcerative Diseases 0.000 claims 3
- OHZBVIJOZXXXCU-VMQLAJLMSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1F)F)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1F)F)N OHZBVIJOZXXXCU-VMQLAJLMSA-N 0.000 claims 3
- 208000002193 Pain Diseases 0.000 claims 3
- 206010063837 Reperfusion injury Diseases 0.000 claims 3
- 208000006011 Stroke Diseases 0.000 claims 3
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 3
- 125000002883 imidazolyl group Chemical group 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 3
- 125000002757 morpholinyl group Chemical group 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 230000036407 pain Effects 0.000 claims 3
- 125000003226 pyrazolyl group Chemical group 0.000 claims 3
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 2
- OMWMIYWQRVOUME-UHFFFAOYSA-N 6-(3-aminopiperidin-1-yl)-n-(4-ethoxyphenyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound C1=CC(OCC)=CC=C1NC1=CC(N2CC(N)CCC2)=NN2C1=NC=C2 OMWMIYWQRVOUME-UHFFFAOYSA-N 0.000 claims 2
- JVLVATQOBJAKQU-UHFFFAOYSA-N 6-(3-aminopropyl)-8-N-(4-ethoxyphenyl)-5H-imidazo[1,2-b]pyridazine-6,8-diamine Chemical compound NCCCC1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)N JVLVATQOBJAKQU-UHFFFAOYSA-N 0.000 claims 2
- OTOBTQSDKOUPCV-UHFFFAOYSA-N 6-piperidin-3-yl-5H-imidazo[1,2-b]pyridazine-6,8-diamine Chemical compound N1N2C=CN=C2C(N)=CC1(N)C1CCCNC1 OTOBTQSDKOUPCV-UHFFFAOYSA-N 0.000 claims 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 2
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 2
- 201000006474 Brain Ischemia Diseases 0.000 claims 2
- TYEWIQQSOVFEQB-AQYVVDRMSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(NC(=O)C=3C(N(C=4C=CC(F)=CC=4)C=CC=3)=O)=CC=2)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(NC(=O)C=3C(N(C=4C=CC(F)=CC=4)C=CC=3)=O)=CC=2)=C1 TYEWIQQSOVFEQB-AQYVVDRMSA-N 0.000 claims 2
- 206010006895 Cachexia Diseases 0.000 claims 2
- 206010008120 Cerebral ischaemia Diseases 0.000 claims 2
- 201000005569 Gout Diseases 0.000 claims 2
- 208000034578 Multiple myelomas Diseases 0.000 claims 2
- REFZOQLBWLWQJG-STFKQGPRSA-N N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)CC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)CC)N REFZOQLBWLWQJG-STFKQGPRSA-N 0.000 claims 2
- RSUHAJFRFKIXPO-OEVKCDGTSA-N N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)Cl)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)Cl)N RSUHAJFRFKIXPO-OEVKCDGTSA-N 0.000 claims 2
- SLLIQXUELFHWMZ-LEWLWEGZSA-N N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=CC=C1)CC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=CC=C1)CC)N SLLIQXUELFHWMZ-LEWLWEGZSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 201000011152 Pemphigus Diseases 0.000 claims 2
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- 201000001263 Psoriatic Arthritis Diseases 0.000 claims 2
- 208000036824 Psoriatic arthropathy Diseases 0.000 claims 2
- 206010037660 Pyrexia Diseases 0.000 claims 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- 206010040070 Septic Shock Diseases 0.000 claims 2
- 230000001154 acute effect Effects 0.000 claims 2
- 125000004450 alkenylene group Chemical group 0.000 claims 2
- 125000004419 alkynylene group Chemical group 0.000 claims 2
- 230000002917 arthritic effect Effects 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 206010008118 cerebral infarction Diseases 0.000 claims 2
- 230000001684 chronic effect Effects 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 208000006454 hepatitis Diseases 0.000 claims 2
- 208000014674 injury Diseases 0.000 claims 2
- 208000010125 myocardial infarction Diseases 0.000 claims 2
- 208000031225 myocardial ischemia Diseases 0.000 claims 2
- 201000001976 pemphigus vulgaris Diseases 0.000 claims 2
- 150000003053 piperidines Chemical class 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- RRXPOLXIYLTJJF-UHFFFAOYSA-N 1-(4-fluorophenyl)-n-[4-(imidazo[1,2-b]pyridazin-8-ylamino)phenyl]-2-oxopiperidine-3-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=CC(NC=3C4=NC=CN4N=CC=3)=CC=2)CCC1 RRXPOLXIYLTJJF-UHFFFAOYSA-N 0.000 claims 1
- NCDDUQLSGLCJJI-UHFFFAOYSA-N 1-(4-fluorophenyl)-n-[4-(imidazo[1,2-b]pyridazin-8-ylamino)phenyl]-2-oxopyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=CC(NC=3C4=NC=CN4N=CC=3)=CC=2)=CC=C1 NCDDUQLSGLCJJI-UHFFFAOYSA-N 0.000 claims 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 claims 1
- CZYTUNVGDISHLR-UHFFFAOYSA-N 2-[1-[8-(4-ethoxyanilino)imidazo[1,2-b]pyridazin-6-yl]piperidin-4-yl]ethanol Chemical compound C1=CC(OCC)=CC=C1NC1=CC(N2CCC(CCO)CC2)=NN2C1=NC=C2 CZYTUNVGDISHLR-UHFFFAOYSA-N 0.000 claims 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 claims 1
- VPXNBUFYFHEGML-UHFFFAOYSA-N 4-[[6-[(4-aminocyclohexyl)amino]-7-methylimidazo[1,2-b]pyridazin-8-yl]amino]-n,n-dimethylbenzenesulfonamide Chemical compound C1=CC(S(=O)(=O)N(C)C)=CC=C1NC1=C(C)C(NC2CCC(N)CC2)=NN2C1=NC=C2 VPXNBUFYFHEGML-UHFFFAOYSA-N 0.000 claims 1
- CVXAFYLGEQSPPQ-UHFFFAOYSA-N 6-(2-aminoethyl)-8-N-(4-ethoxyphenyl)-5H-imidazo[1,2-b]pyridazine-6,8-diamine Chemical compound NCCC1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)N CVXAFYLGEQSPPQ-UHFFFAOYSA-N 0.000 claims 1
- CBOWJEIUBPOKHQ-UHFFFAOYSA-N 6-(3-aminocyclopentyl)-8-N-phenyl-5H-imidazo[1,2-b]pyridazine-6,8-diamine Chemical compound NC1CC(CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=CC=C1)N CBOWJEIUBPOKHQ-UHFFFAOYSA-N 0.000 claims 1
- IYMHHVRRYYJNOK-UHFFFAOYSA-N 6-(3-aminopyrrolidin-1-yl)-n-(4-ethoxyphenyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound C1=CC(OCC)=CC=C1NC1=CC(N2CC(N)CC2)=NN2C1=NC=C2 IYMHHVRRYYJNOK-UHFFFAOYSA-N 0.000 claims 1
- ACQOTGWOTFMBNO-UHFFFAOYSA-N 6-(4-aminobutyl)-8-N-(4-ethoxyphenyl)-5H-imidazo[1,2-b]pyridazine-6,8-diamine Chemical compound NCCCCC1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)N ACQOTGWOTFMBNO-UHFFFAOYSA-N 0.000 claims 1
- RFKGSCKPOUQZLM-UHFFFAOYSA-N 6-(furan-2-ylmethyl)-5H-imidazo[1,2-b]pyridazine-6,8-diamine Chemical compound O1C(=CC=C1)CC1(C=C(C=2N(N1)C=CN=2)N)N RFKGSCKPOUQZLM-UHFFFAOYSA-N 0.000 claims 1
- IYMHHVRRYYJNOK-ZDUSSCGKSA-N 6-[(3s)-3-aminopyrrolidin-1-yl]-n-(4-ethoxyphenyl)imidazo[1,2-b]pyridazin-8-amine Chemical compound C1=CC(OCC)=CC=C1NC1=CC(N2C[C@@H](N)CC2)=NN2C1=NC=C2 IYMHHVRRYYJNOK-ZDUSSCGKSA-N 0.000 claims 1
- SSCCPHFJDLTXMT-UHFFFAOYSA-N 6-[2-(dimethylamino)ethyl]-8-N-(4-ethoxyphenyl)-5H-imidazo[1,2-b]pyridazine-6,8-diamine Chemical compound CN(CCC1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)N)C SSCCPHFJDLTXMT-UHFFFAOYSA-N 0.000 claims 1
- BKHBPNBPPLQSBP-UHFFFAOYSA-N 6-[4-[(4-aminocyclohexyl)methyl]cyclohexyl]-8-N-(4-ethoxyphenyl)-5H-imidazo[1,2-b]pyridazine-6,8-diamine Chemical compound NC1CCC(CC1)CC1CCC(CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)N BKHBPNBPPLQSBP-UHFFFAOYSA-N 0.000 claims 1
- XXTXMMMMXWVDHF-UHFFFAOYSA-N 6-n-(4-aminocyclohexyl)-8-n-(4-ethoxyphenyl)imidazo[1,2-b]pyridazine-6,8-diamine Chemical compound C1=CC(OCC)=CC=C1NC1=CC(NC2CCC(N)CC2)=NN2C1=NC=C2 XXTXMMMMXWVDHF-UHFFFAOYSA-N 0.000 claims 1
- JBYKTGMHTPAFSV-UHFFFAOYSA-N 6-piperidin-4-yl-5H-imidazo[1,2-b]pyridazine-6,8-diamine Chemical compound N1CCC(CC1)C1(C=C(C=2N(N1)C=CN=2)N)N JBYKTGMHTPAFSV-UHFFFAOYSA-N 0.000 claims 1
- PKQGGCSCOKKQRM-UHFFFAOYSA-N 6-pyrrolidin-3-yl-5H-imidazo[1,2-b]pyridazine-6,8-diamine Chemical compound N1CC(CC1)C1(C=C(C=2N(N1)C=CN=2)N)N PKQGGCSCOKKQRM-UHFFFAOYSA-N 0.000 claims 1
- UQLOIYALTVZLPF-UHFFFAOYSA-N 7-chloro-n-(4-ethoxyphenyl)-6-piperazin-1-ylimidazo[1,2-b]pyridazin-8-amine Chemical compound C1=CC(OCC)=CC=C1NC1=C(Cl)C(N2CCNCC2)=NN2C1=NC=C2 UQLOIYALTVZLPF-UHFFFAOYSA-N 0.000 claims 1
- PCDZINPUIMLKAY-UHFFFAOYSA-N 8-n-(4-ethoxyphenyl)-6-n-piperidin-3-ylimidazo[1,2-b]pyridazine-6,8-diamine Chemical compound C1=CC(OCC)=CC=C1NC1=CC(NC2CNCCC2)=NN2C1=NC=C2 PCDZINPUIMLKAY-UHFFFAOYSA-N 0.000 claims 1
- 208000030507 AIDS Diseases 0.000 claims 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 claims 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000036487 Arthropathies Diseases 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 206010055128 Autoimmune neutropenia Diseases 0.000 claims 1
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 claims 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims 1
- 208000023328 Basedow disease Diseases 0.000 claims 1
- 241000713704 Bovine immunodeficiency virus Species 0.000 claims 1
- MAJKMMPTHCJHQW-UHFFFAOYSA-N C(=CC)C=1N=C2N(N=C(C=C2N)N)C1 Chemical compound C(=CC)C=1N=C2N(N=C(C=C2N)N)C1 MAJKMMPTHCJHQW-UHFFFAOYSA-N 0.000 claims 1
- PXYNPNJNRUKQGE-UHFFFAOYSA-N C1(=CC=CC2=CC=CC=C12)C=1N=C2N(N=C(C=C2N)N)C1 Chemical compound C1(=CC=CC2=CC=CC=C12)C=1N=C2N(N=C(C=C2N)N)C1 PXYNPNJNRUKQGE-UHFFFAOYSA-N 0.000 claims 1
- MVDBIBQEHMDKGF-HDJSIYSDSA-N C1=C(O)C(S(=O)(=O)N(C)C)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 Chemical compound C1=C(O)C(S(=O)(=O)N(C)C)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 MVDBIBQEHMDKGF-HDJSIYSDSA-N 0.000 claims 1
- QUKAAEYQRASRQK-JCNLHEQBSA-N C1=CC(C(=O)N(C)C)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 Chemical compound C1=CC(C(=O)N(C)C)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 QUKAAEYQRASRQK-JCNLHEQBSA-N 0.000 claims 1
- FWNWBUROLRVIBF-UAPYVXQJSA-N C1=CC(C(=O)N(CC)CC)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 Chemical compound C1=CC(C(=O)N(CC)CC)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 FWNWBUROLRVIBF-UAPYVXQJSA-N 0.000 claims 1
- WKTJPXUNRVAJMV-SAABIXHNSA-N C1=CC(N(C(C)=O)C)=CC=C1NC1=C(C)C(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 Chemical compound C1=CC(N(C(C)=O)C)=CC=C1NC1=C(C)C(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 WKTJPXUNRVAJMV-SAABIXHNSA-N 0.000 claims 1
- UGFKCXAJYGGZGQ-CZIWCDLHSA-N C1=CC(NC(=O)C)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 Chemical compound C1=CC(NC(=O)C)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 UGFKCXAJYGGZGQ-CZIWCDLHSA-N 0.000 claims 1
- GCLLKMQUUBAPQB-CTYIDZIISA-N C1=CC(NS(=O)(=O)C)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 Chemical compound C1=CC(NS(=O)(=O)C)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 GCLLKMQUUBAPQB-CTYIDZIISA-N 0.000 claims 1
- PDEFJRDSURAZNG-KOMQPUFPSA-N C1=CC(OCC)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2C#N Chemical compound C1=CC(OCC)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2C#N PDEFJRDSURAZNG-KOMQPUFPSA-N 0.000 claims 1
- HBJLBRUEPVJVMT-KOMQPUFPSA-N C1=CC(S(=O)(=O)N(C)C)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 Chemical compound C1=CC(S(=O)(=O)N(C)C)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 HBJLBRUEPVJVMT-KOMQPUFPSA-N 0.000 claims 1
- HBJLBRUEPVJVMT-FZNQNYSPSA-N C1=CC(S(=O)(=O)N(C)C)=CC=C1NC1=CC(N[C@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 Chemical compound C1=CC(S(=O)(=O)N(C)C)=CC=C1NC1=CC(N[C@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 HBJLBRUEPVJVMT-FZNQNYSPSA-N 0.000 claims 1
- NGOXSCLNXQYQBC-SAABIXHNSA-N C1=CC(S(=O)(=O)N(CC)CC)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 Chemical compound C1=CC(S(=O)(=O)N(CC)CC)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 NGOXSCLNXQYQBC-SAABIXHNSA-N 0.000 claims 1
- GMKWUAXBOOWKQY-CTYIDZIISA-N C1=CC(S(=O)(=O)NC)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 Chemical compound C1=CC(S(=O)(=O)NC)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 GMKWUAXBOOWKQY-CTYIDZIISA-N 0.000 claims 1
- DRJSKBUBRZZIMD-KOMQPUFPSA-N C1=CC(S(=O)(=O)NCC)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 Chemical compound C1=CC(S(=O)(=O)NCC)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 DRJSKBUBRZZIMD-KOMQPUFPSA-N 0.000 claims 1
- QYDKHWOLAUZKDL-JCNLHEQBSA-N C1=CC(S(=O)(=O)NCCC)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 Chemical compound C1=CC(S(=O)(=O)NCCC)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 QYDKHWOLAUZKDL-JCNLHEQBSA-N 0.000 claims 1
- IMZWNAMEVWZZHQ-IYARVYRRSA-N C1CCC2=CC(C)=CC=C2N1C(C1=NC=CN1N=1)=CC=1N[C@H]1CC[C@H](N)CC1 Chemical compound C1CCC2=CC(C)=CC=C2N1C(C1=NC=CN1N=1)=CC=1N[C@H]1CC[C@H](N)CC1 IMZWNAMEVWZZHQ-IYARVYRRSA-N 0.000 claims 1
- VJIPYULVLXMZOC-CTYIDZIISA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C(C#N)=CN=C2C(NC=2C=CC=CC=2)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C(C#N)=CN=C2C(NC=2C=CC=CC=2)=C1 VJIPYULVLXMZOC-CTYIDZIISA-N 0.000 claims 1
- ISLYOFBOHHGXPK-MQMHXKEQSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C(C(N)=O)=CN=C2C(NC=2C=CC=CC=2)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C(C(N)=O)=CN=C2C(NC=2C=CC=CC=2)=C1 ISLYOFBOHHGXPK-MQMHXKEQSA-N 0.000 claims 1
- IEOYOODRCOAEMG-SHTZXODSSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC(=O)C=2C=CC=CC=2)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC(=O)C=2C=CC=CC=2)=C1 IEOYOODRCOAEMG-SHTZXODSSA-N 0.000 claims 1
- MDDIJEDLJOBHEY-CTYIDZIISA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC(=O)NC=2C=CC=CC=2)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC(=O)NC=2C=CC=CC=2)=C1 MDDIJEDLJOBHEY-CTYIDZIISA-N 0.000 claims 1
- ZSFRWNNKBMIOOC-JOCQHMNTSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C(=CC=CC=2)O)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C(=CC=CC=2)O)=C1 ZSFRWNNKBMIOOC-JOCQHMNTSA-N 0.000 claims 1
- ADXLFHFPANLMRH-SHTZXODSSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=C(C=CC=2)C#N)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=C(C=CC=2)C#N)=C1 ADXLFHFPANLMRH-SHTZXODSSA-N 0.000 claims 1
- BDONQTAZVMDUST-KESTWPANSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=C(C=CC=2)C(=O)NC=2C=CC=CC=2)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=C(C=CC=2)C(=O)NC=2C=CC=CC=2)=C1 BDONQTAZVMDUST-KESTWPANSA-N 0.000 claims 1
- INILGZLACGMTIF-HDJSIYSDSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=C(C=CC=2)C(O)=O)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=C(C=CC=2)C(O)=O)=C1 INILGZLACGMTIF-HDJSIYSDSA-N 0.000 claims 1
- BIUNZHGGBJCAFD-JOCQHMNTSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=C(O)C=CC=2)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=C(O)C=CC=2)=C1 BIUNZHGGBJCAFD-JOCQHMNTSA-N 0.000 claims 1
- WNTXSFQCBNVJHJ-HAQNSBGRSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=C3C(C(NN3)=O)=CC=2)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=C3C(C(NN3)=O)=CC=2)=C1 WNTXSFQCBNVJHJ-HAQNSBGRSA-N 0.000 claims 1
- FVKAFOLBMYXPDE-KOMQPUFPSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(=CC=2)C#N)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(=CC=2)C#N)=C1 FVKAFOLBMYXPDE-KOMQPUFPSA-N 0.000 claims 1
- YVKBJIQOGDHJFK-JCNLHEQBSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(=CC=2)C(=O)NC2CC2)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(=CC=2)C(=O)NC2CC2)=C1 YVKBJIQOGDHJFK-JCNLHEQBSA-N 0.000 claims 1
- OTQZKRUKKZZWHM-XGAFWQRZSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(=CC=2)C(=O)NC2CCCCC2)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(=CC=2)C(=O)NC2CCCCC2)=C1 OTQZKRUKKZZWHM-XGAFWQRZSA-N 0.000 claims 1
- CSYCDTJUIFWHKD-XGAFWQRZSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(=CC=2)C(=O)NC=2C=CC=CC=2)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(=CC=2)C(=O)NC=2C=CC=CC=2)=C1 CSYCDTJUIFWHKD-XGAFWQRZSA-N 0.000 claims 1
- RMABXBZIZGPZPV-UAPYVXQJSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(=CC=2)C(=O)NC=2C=NC=CC=2)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(=CC=2)C(=O)NC=2C=NC=CC=2)=C1 RMABXBZIZGPZPV-UAPYVXQJSA-N 0.000 claims 1
- BFRUMZZTBHOIAP-CTYIDZIISA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(=CC=2)C(O)=O)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(=CC=2)C(O)=O)=C1 BFRUMZZTBHOIAP-CTYIDZIISA-N 0.000 claims 1
- HQFSOLPHORNRIV-MQMHXKEQSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(=CC=2)S(O)(=O)=O)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(=CC=2)S(O)(=O)=O)=C1 HQFSOLPHORNRIV-MQMHXKEQSA-N 0.000 claims 1
- MPBKGMFEWBLBKS-KESTWPANSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(NC(=O)C=3C=CC=CC=3)=CC=2)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(NC(=O)C=3C=CC=CC=3)=CC=2)=C1 MPBKGMFEWBLBKS-KESTWPANSA-N 0.000 claims 1
- PCUTWNIUUUWMIF-IRJFHVNHSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(NC(=O)NC=3C=CC=CC=3)=CC=2)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(NC(=O)NC=3C=CC=CC=3)=CC=2)=C1 PCUTWNIUUUWMIF-IRJFHVNHSA-N 0.000 claims 1
- QUQLQIANWFAGOL-MQMHXKEQSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(O)=CC=2)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NC=2C=CC(O)=CC=2)=C1 QUQLQIANWFAGOL-MQMHXKEQSA-N 0.000 claims 1
- GAMHGYMOZVTGIY-HDJSIYSDSA-N C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NS(=O)(=O)C=2C=CC=CC=2)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1NC1=NN2C=CN=C2C(NS(=O)(=O)C=2C=CC=CC=2)=C1 GAMHGYMOZVTGIY-HDJSIYSDSA-N 0.000 claims 1
- LOYSCGPAOMSQLY-SAZUREKKSA-N C1C[C@@H](N)CC[C@@H]1OC1=NN2C(C#N)=CN=C2C(NC=2C=CC=CC=2)=C1 Chemical compound C1C[C@@H](N)CC[C@@H]1OC1=NN2C(C#N)=CN=C2C(NC=2C=CC=CC=2)=C1 LOYSCGPAOMSQLY-SAZUREKKSA-N 0.000 claims 1
- JDUSRQVIGTWHDZ-YHBQERECSA-N C=1C=C(NC(=O)C=2C(N(C=3C=CC(F)=CC=3)C=CC=2)=O)C(CC)=CC=1NC(C1=NC=CN1N=1)=CC=1N[C@H]1CC[C@H](N)CC1 Chemical compound C=1C=C(NC(=O)C=2C(N(C=3C=CC(F)=CC=3)C=CC=2)=O)C(CC)=CC=1NC(C1=NC=CN1N=1)=CC=1N[C@H]1CC[C@H](N)CC1 JDUSRQVIGTWHDZ-YHBQERECSA-N 0.000 claims 1
- AKZJWJDJWCETKU-WGSAOQKQSA-N C=1C=CC(NC=2C3=NC=CN3N=C(N[C@@H]3CC[C@@H](N)CC3)C=2)=CC=1S(=O)(=O)N(C)C1=CC=CC=C1 Chemical compound C=1C=CC(NC=2C3=NC=CN3N=C(N[C@@H]3CC[C@@H](N)CC3)C=2)=CC=1S(=O)(=O)N(C)C1=CC=CC=C1 AKZJWJDJWCETKU-WGSAOQKQSA-N 0.000 claims 1
- IAFVJHYMWOANDB-IYARVYRRSA-N CCN(CC)C(=O)C1=CC=CC(NC=2C3=NC=CN3N=C(N[C@@H]3CC[C@@H](N)CC3)C=2)=C1 Chemical compound CCN(CC)C(=O)C1=CC=CC(NC=2C3=NC=CN3N=C(N[C@@H]3CC[C@@H](N)CC3)C=2)=C1 IAFVJHYMWOANDB-IYARVYRRSA-N 0.000 claims 1
- DBIRSRRZQVDPIS-SHTZXODSSA-N CN(C)S(=O)(=O)C1=CC=CC(NC=2C3=NC=CN3N=C(N[C@@H]3CC[C@@H](N)CC3)C=2)=C1 Chemical compound CN(C)S(=O)(=O)C1=CC=CC(NC=2C3=NC=CN3N=C(N[C@@H]3CC[C@@H](N)CC3)C=2)=C1 DBIRSRRZQVDPIS-SHTZXODSSA-N 0.000 claims 1
- DFCMSUYLMZXEDW-VNHLFDKOSA-N CN[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=CC=C1)N Chemical compound CN[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=CC=C1)N DFCMSUYLMZXEDW-VNHLFDKOSA-N 0.000 claims 1
- 241000282465 Canis Species 0.000 claims 1
- 206010007572 Cardiac hypertrophy Diseases 0.000 claims 1
- 208000006029 Cardiomegaly Diseases 0.000 claims 1
- 206010063094 Cerebral malaria Diseases 0.000 claims 1
- 206010008909 Chronic Hepatitis Diseases 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims 1
- WMIMGJFRMNPCHO-SUBVVYJRSA-N ClC1=NC=CC(=N1)N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=CC=C1)N Chemical compound ClC1=NC=CC(=N1)N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=CC=C1)N WMIMGJFRMNPCHO-SUBVVYJRSA-N 0.000 claims 1
- 208000032170 Congenital Abnormalities Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 206010048843 Cytomegalovirus chorioretinitis Diseases 0.000 claims 1
- 206010061619 Deformity Diseases 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 208000037487 Endotoxemia Diseases 0.000 claims 1
- 241000713730 Equine infectious anemia virus Species 0.000 claims 1
- 241000713800 Feline immunodeficiency virus Species 0.000 claims 1
- 206010018364 Glomerulonephritis Diseases 0.000 claims 1
- 206010018634 Gouty Arthritis Diseases 0.000 claims 1
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 1
- 208000015023 Graves' disease Diseases 0.000 claims 1
- 208000031886 HIV Infections Diseases 0.000 claims 1
- 208000037357 HIV infectious disease Diseases 0.000 claims 1
- 206010018910 Haemolysis Diseases 0.000 claims 1
- 206010019233 Headaches Diseases 0.000 claims 1
- 208000005176 Hepatitis C Diseases 0.000 claims 1
- 206010019755 Hepatitis chronic active Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 206010021143 Hypoxia Diseases 0.000 claims 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 claims 1
- 206010061598 Immunodeficiency Diseases 0.000 claims 1
- 208000029462 Immunodeficiency disease Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 208000012659 Joint disease Diseases 0.000 claims 1
- 208000007766 Kaposi sarcoma Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 206010027480 Metastatic malignant melanoma Diseases 0.000 claims 1
- 241000907681 Morpho Species 0.000 claims 1
- 206010028289 Muscle atrophy Diseases 0.000 claims 1
- 208000000112 Myalgia Diseases 0.000 claims 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 claims 1
- CJUABQXTORYFJG-JCNLHEQBSA-N N=1N2C(C#N)=CN=C2C(NC=2C=CC=CC=2)=C(C(C)C)C=1N[C@H]1CC[C@H](N)CC1 Chemical compound N=1N2C(C#N)=CN=C2C(NC=2C=CC=CC=2)=C(C(C)C)C=1N[C@H]1CC[C@H](N)CC1 CJUABQXTORYFJG-JCNLHEQBSA-N 0.000 claims 1
- XPYOLEKDJLCFMY-KOMQPUFPSA-N N=1N2C(C#N)=CN=C2C(NC=2C=CC=CC=2)=C(CC)C=1N[C@H]1CC[C@H](N)CC1 Chemical compound N=1N2C(C#N)=CN=C2C(NC=2C=CC=CC=2)=C(CC)C=1N[C@H]1CC[C@H](N)CC1 XPYOLEKDJLCFMY-KOMQPUFPSA-N 0.000 claims 1
- FFUQTVMHEOZHDE-HDJSIYSDSA-N N=1N2C=CN=C2C(NC=2C=C(O)C=CC=2)=C(C)C=1N[C@H]1CC[C@H](N)CC1 Chemical compound N=1N2C=CN=C2C(NC=2C=C(O)C=CC=2)=C(C)C=1N[C@H]1CC[C@H](N)CC1 FFUQTVMHEOZHDE-HDJSIYSDSA-N 0.000 claims 1
- JYEQQYUSNBKXRA-KOMQPUFPSA-N N=1N2C=CN=C2C(NC=2C=CC(=CC=2)C(O)=O)=C(C)C=1N[C@H]1CC[C@H](N)CC1 Chemical compound N=1N2C=CN=C2C(NC=2C=CC(=CC=2)C(O)=O)=C(C)C=1N[C@H]1CC[C@H](N)CC1 JYEQQYUSNBKXRA-KOMQPUFPSA-N 0.000 claims 1
- XXJDONDSTFIQFR-RVWIWJKTSA-N N=1N2C=CN=C2C(NC=2C=CC(NC(=O)NC=3C=CC=CC=3)=CC=2)=C(C)C=1N[C@@H]1CC[C@H](N)CC1 Chemical compound N=1N2C=CN=C2C(NC=2C=CC(NC(=O)NC=3C=CC=CC=3)=CC=2)=C(C)C=1N[C@@H]1CC[C@H](N)CC1 XXJDONDSTFIQFR-RVWIWJKTSA-N 0.000 claims 1
- XXJDONDSTFIQFR-XGAFWQRZSA-N N=1N2C=CN=C2C(NC=2C=CC(NC(=O)NC=3C=CC=CC=3)=CC=2)=C(C)C=1N[C@H]1CC[C@H](N)CC1 Chemical compound N=1N2C=CN=C2C(NC=2C=CC(NC(=O)NC=3C=CC=CC=3)=CC=2)=C(C)C=1N[C@H]1CC[C@H](N)CC1 XXJDONDSTFIQFR-XGAFWQRZSA-N 0.000 claims 1
- ATWFZNOGSSFTRH-UHFFFAOYSA-N NC12CCC(CC1)(CC2)C2(C=C(C=1N(N2)C=CN1)NC1=CC=CC=C1)N Chemical compound NC12CCC(CC1)(CC2)C2(C=C(C=1N(N2)C=CN1)NC1=CC=CC=C1)N ATWFZNOGSSFTRH-UHFFFAOYSA-N 0.000 claims 1
- ZCSGJAIKSQWCTI-SKIQCWHVSA-N N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)C)C)N ZCSGJAIKSQWCTI-SKIQCWHVSA-N 0.000 claims 1
- KTCGSOHAQRQYQG-FDTIFPJHSA-N N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)F)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)F)C)N KTCGSOHAQRQYQG-FDTIFPJHSA-N 0.000 claims 1
- WLXFVNINQOCAOK-UYJZDEDHSA-N N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC(=C(C=C1)C)C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC(=C(C=C1)C)C)C)N WLXFVNINQOCAOK-UYJZDEDHSA-N 0.000 claims 1
- CQKYAXLNCPPXOT-LEWLWEGZSA-N N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)OC)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)OC)C)N CQKYAXLNCPPXOT-LEWLWEGZSA-N 0.000 claims 1
- UOYRFHNBVIAWQY-SKIQCWHVSA-N N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C)C)N UOYRFHNBVIAWQY-SKIQCWHVSA-N 0.000 claims 1
- HXIWIASHMJESLP-FPCUACJBSA-N N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C1=CC=CC=C1)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C1=CC=CC=C1)C)N HXIWIASHMJESLP-FPCUACJBSA-N 0.000 claims 1
- PALBPIZKZBAGCW-CZEDARRBSA-N N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)C)N PALBPIZKZBAGCW-CZEDARRBSA-N 0.000 claims 1
- OTGBKQRZQSOPSC-NMUBWLRRSA-N N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)C1=CC=CC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)C1=CC=CC=C1)N OTGBKQRZQSOPSC-NMUBWLRRSA-N 0.000 claims 1
- MOEJXZJVQBRYCN-VHPWLNBFSA-N N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCCC)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCCC)C)N MOEJXZJVQBRYCN-VHPWLNBFSA-N 0.000 claims 1
- BEIWDVYGHWPNRP-VNHLFDKOSA-N N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=CC=C1)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=CC=C1)C)N BEIWDVYGHWPNRP-VNHLFDKOSA-N 0.000 claims 1
- LKDADLNTHXOWJS-MEQCVUQCSA-N N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=CC=C1)C1=CC=CC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=CC=C1)C1=CC=CC=C1)N LKDADLNTHXOWJS-MEQCVUQCSA-N 0.000 claims 1
- NRHCQLDXFYQCLI-VHPWLNBFSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C(=C(N=2)C)C)NC1=CC=C(C=C1)OCC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C(=C(N=2)C)C)NC1=CC=C(C=C1)OCC)N NRHCQLDXFYQCLI-VHPWLNBFSA-N 0.000 claims 1
- HJWPDXYJPMHWNU-CZEDARRBSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C(=CN=2)C)NC1=CC=C(C=C1)OCC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C(=CN=2)C)NC1=CC=C(C=C1)OCC)N HJWPDXYJPMHWNU-CZEDARRBSA-N 0.000 claims 1
- UQXHYMMXBGFAQP-OEVKCDGTSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C(=CN=2)F)NC1=CC=C(C=C1)OCC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C(=CN=2)F)NC1=CC=C(C=C1)OCC)N UQXHYMMXBGFAQP-OEVKCDGTSA-N 0.000 claims 1
- IDPWXWBTFBQFRM-VNHLFDKOSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)N(C1=CC=CC=C1)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)N(C1=CC=CC=C1)C)N IDPWXWBTFBQFRM-VNHLFDKOSA-N 0.000 claims 1
- IZWNUNUHGIYTIL-UFXILDGNSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)N)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)N)N IZWNUNUHGIYTIL-UFXILDGNSA-N 0.000 claims 1
- MMSQKFFUFMKZJD-QWJAPKFZSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC(C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC(C)C)N MMSQKFFUFMKZJD-QWJAPKFZSA-N 0.000 claims 1
- PVQBJQUJXRPLHT-SKIQCWHVSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C(=CC=C1)C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C(=CC=C1)C)C)N PVQBJQUJXRPLHT-SKIQCWHVSA-N 0.000 claims 1
- RIUFKJFLYPGUOR-VMQLAJLMSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C(=CC=C1)F)F)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C(=CC=C1)F)F)N RIUFKJFLYPGUOR-VMQLAJLMSA-N 0.000 claims 1
- VGXQUDMZFAUEHE-SKIQCWHVSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=C(C=C1)C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=C(C=C1)C)C)N VGXQUDMZFAUEHE-SKIQCWHVSA-N 0.000 claims 1
- GHYNOJCJPCZNFN-FDTIFPJHSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=C(C=C1)C)F)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=C(C=C1)C)F)N GHYNOJCJPCZNFN-FDTIFPJHSA-N 0.000 claims 1
- HGCCZCWMFFJMPA-YVTDUHFPSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=C(C=C1)Cl)F)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=C(C=C1)Cl)F)N HGCCZCWMFFJMPA-YVTDUHFPSA-N 0.000 claims 1
- PIYICUXHSFIUQC-YVTDUHFPSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=C(C=C1)F)F)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=C(C=C1)F)F)N PIYICUXHSFIUQC-YVTDUHFPSA-N 0.000 claims 1
- VNNWMOARFZTNEE-SKIQCWHVSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC(=C1)C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC(=C1)C)C)N VNNWMOARFZTNEE-SKIQCWHVSA-N 0.000 claims 1
- CADUNQFDLPZGQY-FDTIFPJHSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC(=C1)C)F)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC(=C1)C)F)N CADUNQFDLPZGQY-FDTIFPJHSA-N 0.000 claims 1
- KBHQKUBNJZASOH-YVTDUHFPSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC(=C1)F)F)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC(=C1)F)F)N KBHQKUBNJZASOH-YVTDUHFPSA-N 0.000 claims 1
- OMCBYLUFQJTBBK-VNHLFDKOSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)C)N OMCBYLUFQJTBBK-VNHLFDKOSA-N 0.000 claims 1
- IXQQZDHUOUSZAL-SKIQCWHVSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)CC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)CC)N IXQQZDHUOUSZAL-SKIQCWHVSA-N 0.000 claims 1
- PWQZARQTEOKDHG-IILDZGFYSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)Cl)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)Cl)N PWQZARQTEOKDHG-IILDZGFYSA-N 0.000 claims 1
- MOHXMGPRIMZMPS-IILDZGFYSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)F)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)F)N MOHXMGPRIMZMPS-IILDZGFYSA-N 0.000 claims 1
- KHEMZVVOZHMJBZ-FDTIFPJHSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)OC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)OC)N KHEMZVVOZHMJBZ-FDTIFPJHSA-N 0.000 claims 1
- VBFWBZFTJYYXJZ-NUJJYFHVSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)OC1=CC=CC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)OC1=CC=CC=C1)N VBFWBZFTJYYXJZ-NUJJYFHVSA-N 0.000 claims 1
- OTMLWTQEYXVYCJ-LEWLWEGZSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)OCC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)OCC)N OTMLWTQEYXVYCJ-LEWLWEGZSA-N 0.000 claims 1
- NAHGNMMZARHRAH-FDTIFPJHSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=C(C=C1)C)C(F)(F)F)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=C(C=C1)C)C(F)(F)F)N NAHGNMMZARHRAH-FDTIFPJHSA-N 0.000 claims 1
- LHHNVACGOMAYAU-SKIQCWHVSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=C(C=C1)C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=C(C=C1)C)C)N LHHNVACGOMAYAU-SKIQCWHVSA-N 0.000 claims 1
- AEGMGILIWDBIFV-FDTIFPJHSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=C(C=C1)C)F)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=C(C=C1)C)F)N AEGMGILIWDBIFV-FDTIFPJHSA-N 0.000 claims 1
- FLLQCHGZLWBCTB-FDTIFPJHSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=C(C=C1)Cl)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=C(C=C1)Cl)C)N FLLQCHGZLWBCTB-FDTIFPJHSA-N 0.000 claims 1
- XASDFAJYQZKBBH-FDTIFPJHSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=C(C=C1)F)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=C(C=C1)F)C)N XASDFAJYQZKBBH-FDTIFPJHSA-N 0.000 claims 1
- FGLUGLHPXTWHAW-VMQLAJLMSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=C(C=C1)F)F)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=C(C=C1)F)F)N FGLUGLHPXTWHAW-VMQLAJLMSA-N 0.000 claims 1
- JYRZJTQPZGDBJT-OEVKCDGTSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=C(C=C1)OC)OC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=C(C=C1)OC)OC)N JYRZJTQPZGDBJT-OEVKCDGTSA-N 0.000 claims 1
- WUWBTSSNUOVTDJ-SKIQCWHVSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC(=C1)C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC(=C1)C)C)N WUWBTSSNUOVTDJ-SKIQCWHVSA-N 0.000 claims 1
- BGKQTOVKPOPFPK-ZZABYMOQSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC(=C1)Cl)Cl)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC(=C1)Cl)Cl)N BGKQTOVKPOPFPK-ZZABYMOQSA-N 0.000 claims 1
- HQKXEBPQWIFWSB-ZZABYMOQSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC(=C1)F)F)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC(=C1)F)F)N HQKXEBPQWIFWSB-ZZABYMOQSA-N 0.000 claims 1
- SAPNJWXKGFDGFN-OEVKCDGTSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC(=C1)OC)OC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC(=C1)OC)OC)N SAPNJWXKGFDGFN-OEVKCDGTSA-N 0.000 claims 1
- QOYMUHJYYXLGJU-UYJZDEDHSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)C(C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)C(C)C)N QOYMUHJYYXLGJU-UYJZDEDHSA-N 0.000 claims 1
- ROVKYFLWBFLGDC-FWNFJVJXSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)C(F)(F)F)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)C(F)(F)F)N ROVKYFLWBFLGDC-FWNFJVJXSA-N 0.000 claims 1
- XARXBIYGRVKRLD-VNHLFDKOSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)C)N XARXBIYGRVKRLD-VNHLFDKOSA-N 0.000 claims 1
- XUDOYLCTEBBJCW-SKIQCWHVSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)CC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)CC)N XUDOYLCTEBBJCW-SKIQCWHVSA-N 0.000 claims 1
- GWNMWOABOPWFGV-FPCUACJBSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)CC1=CC=CC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)CC1=CC=CC=C1)N GWNMWOABOPWFGV-FPCUACJBSA-N 0.000 claims 1
- FSPBQQOGEAFXSC-VNHLFDKOSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)CN)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)CN)N FSPBQQOGEAFXSC-VNHLFDKOSA-N 0.000 claims 1
- RRWGQLGTGDOZNU-FWNFJVJXSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)Cl)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)Cl)N RRWGQLGTGDOZNU-FWNFJVJXSA-N 0.000 claims 1
- LGVBXKMJDHEQED-FWNFJVJXSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)F)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)F)N LGVBXKMJDHEQED-FWNFJVJXSA-N 0.000 claims 1
- YDZRXGZTGNHQPR-LEWLWEGZSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)N(C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)N(C)C)N YDZRXGZTGNHQPR-LEWLWEGZSA-N 0.000 claims 1
- XFSLQFZUSQTRFJ-CZEDARRBSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)OC(C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)OC(C)C)N XFSLQFZUSQTRFJ-CZEDARRBSA-N 0.000 claims 1
- RKJCWONUBSBCES-IILDZGFYSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)OC(F)(F)F)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)OC(F)(F)F)N RKJCWONUBSBCES-IILDZGFYSA-N 0.000 claims 1
- IHFJMSFAYKXBEX-FDTIFPJHSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)OC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)OC)N IHFJMSFAYKXBEX-FDTIFPJHSA-N 0.000 claims 1
- PPUIYKZQZHFHSR-NUJJYFHVSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)OC1=CC=CC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)OC1=CC=CC=C1)N PPUIYKZQZHFHSR-NUJJYFHVSA-N 0.000 claims 1
- CAJYIIMSKDBEJA-LEWLWEGZSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)OCC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)OCC)N CAJYIIMSKDBEJA-LEWLWEGZSA-N 0.000 claims 1
- VYRFJOMMEIPNEO-YYSPQECZSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)OCC1=CC=CC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)OCC1=CC=CC=C1)N VYRFJOMMEIPNEO-YYSPQECZSA-N 0.000 claims 1
- YTRCEFFRSRSQOE-VHPWLNBFSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)S(=O)(=O)N1CCOCC1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)S(=O)(=O)N1CCOCC1)N YTRCEFFRSRSQOE-VHPWLNBFSA-N 0.000 claims 1
- OJNGVJLBWLDVSI-FDTIFPJHSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)SC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=CC=C1)SC)N OJNGVJLBWLDVSI-FDTIFPJHSA-N 0.000 claims 1
- UFBXEHDGKIINGJ-CVBNSBKJSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=NC=C1)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=NC=C1)C)N UFBXEHDGKIINGJ-CVBNSBKJSA-N 0.000 claims 1
- COKZSUPVIZSYAB-OEVKCDGTSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC2=C(N=C(S2)C)C=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC2=C(N=C(S2)C)C=C1)N COKZSUPVIZSYAB-OEVKCDGTSA-N 0.000 claims 1
- JVIHGOUHHDJYDY-DFPMAXHOSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=2CC3=CC=CC=C3C=2C=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=2CC3=CC=CC=C3C=2C=C1)N JVIHGOUHHDJYDY-DFPMAXHOSA-N 0.000 claims 1
- CMIXQGQRGPIXDF-VTBPVJSFSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C2=CC=CC=C12)Cl)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C2=CC=CC=C12)Cl)N CMIXQGQRGPIXDF-VTBPVJSFSA-N 0.000 claims 1
- IFFDLHHGGMPJEX-BVWRGAJNSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C(=O)N1CC(CC1)C1=CC=CC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C(=O)N1CC(CC1)C1=CC=CC=C1)N IFFDLHHGGMPJEX-BVWRGAJNSA-N 0.000 claims 1
- DGRXBWCGUKGYIC-BIBMFLLGSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C(=O)N1CCC(CC1)C1=CC=CC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C(=O)N1CCC(CC1)C1=CC=CC=C1)N DGRXBWCGUKGYIC-BIBMFLLGSA-N 0.000 claims 1
- TZAYVAYGPISLSC-NCHKGXLSSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C(=O)N1CCCC1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C(=O)N1CCCC1)N TZAYVAYGPISLSC-NCHKGXLSSA-N 0.000 claims 1
- JGSAUJSOCHLKMD-MEQCVUQCSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C(=O)N1CCCCC1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C(=O)N1CCCCC1)N JGSAUJSOCHLKMD-MEQCVUQCSA-N 0.000 claims 1
- HWCIBUNZNBVAIM-NCHKGXLSSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C(=O)N1CCOCC1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C(=O)N1CCOCC1)N HWCIBUNZNBVAIM-NCHKGXLSSA-N 0.000 claims 1
- IYBZEEBLGJSTOI-VHPWLNBFSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C(C)(C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C(C)(C)C)N IYBZEEBLGJSTOI-VHPWLNBFSA-N 0.000 claims 1
- FVVBBLLTLVOSOH-UYJZDEDHSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C(C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C(C)C)N FVVBBLLTLVOSOH-UYJZDEDHSA-N 0.000 claims 1
- QBHWLYLCCKTZBI-FWNFJVJXSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C(F)(F)F)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C(F)(F)F)N QBHWLYLCCKTZBI-FWNFJVJXSA-N 0.000 claims 1
- UFJPJJXAHOSMCF-VNHLFDKOSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C)N UFJPJJXAHOSMCF-VNHLFDKOSA-N 0.000 claims 1
- HMBGJHORMPPBSZ-CZEDARRBSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C1=NN=CN1C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C1=NN=CN1C)N HMBGJHORMPPBSZ-CZEDARRBSA-N 0.000 claims 1
- NGBYPEWTMGLOBH-FDTIFPJHSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C1=NN=NN1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C1=NN=NN1)N NGBYPEWTMGLOBH-FDTIFPJHSA-N 0.000 claims 1
- WTEFSENXCICSHK-OPYUEGPBSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C1CCCCC1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C1CCCCC1)N WTEFSENXCICSHK-OPYUEGPBSA-N 0.000 claims 1
- CHBHVMVOBVOKRX-VHPWLNBFSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C=1N(C=CN=1)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C=1N(C=CN=1)C)N CHBHVMVOBVOKRX-VHPWLNBFSA-N 0.000 claims 1
- ZNBLCHCINPCXKQ-VHPWLNBFSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C=1N=C(SC=1)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C=1N=C(SC=1)C)N ZNBLCHCINPCXKQ-VHPWLNBFSA-N 0.000 claims 1
- MOKRRSVDGBHMEJ-CZEDARRBSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C=1N=NN(N=1)CC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C=1N=NN(N=1)CC)N MOKRRSVDGBHMEJ-CZEDARRBSA-N 0.000 claims 1
- KJENEPPROHXPFA-NCHKGXLSSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C=1OC(=CC=1)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C=1OC(=CC=1)C)N KJENEPPROHXPFA-NCHKGXLSSA-N 0.000 claims 1
- PHMSNUGINNALNS-SKIQCWHVSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)CC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)CC)N PHMSNUGINNALNS-SKIQCWHVSA-N 0.000 claims 1
- VNVCBOPGANJFJK-FPCUACJBSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)CC1=CC=CC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)CC1=CC=CC=C1)N VNVCBOPGANJFJK-FPCUACJBSA-N 0.000 claims 1
- NWNIBHFWISQWIG-UYJZDEDHSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)CCC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)CCC)N NWNIBHFWISQWIG-UYJZDEDHSA-N 0.000 claims 1
- RKNWKZFOZRGREJ-IQHDZCMKSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)CCCC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)CCCC)N RKNWKZFOZRGREJ-IQHDZCMKSA-N 0.000 claims 1
- BUUYMXSVXGMJGX-VNHLFDKOSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)CN)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)CN)N BUUYMXSVXGMJGX-VNHLFDKOSA-N 0.000 claims 1
- RVGKCIVZVIPKJV-FWNFJVJXSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)Cl)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)Cl)N RVGKCIVZVIPKJV-FWNFJVJXSA-N 0.000 claims 1
- YWYBAAAKWJXBFP-FWNFJVJXSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)F)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)F)N YWYBAAAKWJXBFP-FWNFJVJXSA-N 0.000 claims 1
- GHXMSUZSNTYLTL-IILDZGFYSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N)N GHXMSUZSNTYLTL-IILDZGFYSA-N 0.000 claims 1
- ZLOUVWJCDULNFM-VHPWLNBFSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N1C=CC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N1C=CC=C1)N ZLOUVWJCDULNFM-VHPWLNBFSA-N 0.000 claims 1
- VWTRHAPMQUZVEO-OLZRQOMDSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N1C=NC(=C1Cl)Cl)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N1C=NC(=C1Cl)Cl)N VWTRHAPMQUZVEO-OLZRQOMDSA-N 0.000 claims 1
- DYPVIDIWRNKKGQ-CZEDARRBSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N1C=NC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N1C=NC=C1)N DYPVIDIWRNKKGQ-CZEDARRBSA-N 0.000 claims 1
- JDMVLZPTTYUUQR-VCUMQWCCSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N1CC(CC1)N(C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N1CC(CC1)N(C)C)N JDMVLZPTTYUUQR-VCUMQWCCSA-N 0.000 claims 1
- OMLLNRBWHOWEIO-VHPWLNBFSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N1CCOCC1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N1CCOCC1)N OMLLNRBWHOWEIO-VHPWLNBFSA-N 0.000 claims 1
- LVYXZNIWTFZLLA-NCHKGXLSSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N1N=C(C=C1C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N1N=C(C=C1C)C)N LVYXZNIWTFZLLA-NCHKGXLSSA-N 0.000 claims 1
- HFXXHRRHJVEWFW-CZEDARRBSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N1N=CC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N1N=CC=C1)N HFXXHRRHJVEWFW-CZEDARRBSA-N 0.000 claims 1
- NLGSXSQLLRWQAP-LEWLWEGZSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N1N=CN=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N1N=CN=C1)N NLGSXSQLLRWQAP-LEWLWEGZSA-N 0.000 claims 1
- BVQURZUKPUUNIK-CZEDARRBSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OC(C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OC(C)C)N BVQURZUKPUUNIK-CZEDARRBSA-N 0.000 claims 1
- HULGBACORKMDFG-FDTIFPJHSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OC)N HULGBACORKMDFG-FDTIFPJHSA-N 0.000 claims 1
- CBISPAOZZHXWHW-NUJJYFHVSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OC1=CC=CC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OC1=CC=CC=C1)N CBISPAOZZHXWHW-NUJJYFHVSA-N 0.000 claims 1
- NOEMIGDHWXPJCB-YYSPQECZSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC1=CC=CC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC1=CC=CC=C1)N NOEMIGDHWXPJCB-YYSPQECZSA-N 0.000 claims 1
- YQZBNRILLRJZMV-CZEDARRBSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCCC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCCC)N YQZBNRILLRJZMV-CZEDARRBSA-N 0.000 claims 1
- FCKBDKOTJWJGGS-VHPWLNBFSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCCCC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCCCC)N FCKBDKOTJWJGGS-VHPWLNBFSA-N 0.000 claims 1
- FCDFQXUZXVBRJE-VHPWLNBFSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)S(=O)(=O)N1CCCC1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)S(=O)(=O)N1CCCC1)N FCDFQXUZXVBRJE-VHPWLNBFSA-N 0.000 claims 1
- UZWOTZRMAFQZLV-FDTIFPJHSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)SC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)SC)N UZWOTZRMAFQZLV-FDTIFPJHSA-N 0.000 claims 1
- MWEVZGDZQRMVPI-VHPWLNBFSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=CC2=CC=CC=C12)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=CC2=CC=CC=C12)N MWEVZGDZQRMVPI-VHPWLNBFSA-N 0.000 claims 1
- IBVZGUHXUCAFGO-VHPWLNBFSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=CC=2CCCCC1=2)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=CC=2CCCCC1=2)N IBVZGUHXUCAFGO-VHPWLNBFSA-N 0.000 claims 1
- CUWNJBPRURJXKO-CVBNSBKJSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=CC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=CC=C1)N CUWNJBPRURJXKO-CVBNSBKJSA-N 0.000 claims 1
- RQLNPAQKYIPXMQ-VNHLFDKOSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC(=CC(=C1)C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC(=CC(=C1)C)C)N RQLNPAQKYIPXMQ-VNHLFDKOSA-N 0.000 claims 1
- DLRQPFZFVKERIS-CVBNSBKJSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC=C(C=C1)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC=C(C=C1)C)N DLRQPFZFVKERIS-CVBNSBKJSA-N 0.000 claims 1
- VUIRXWAMPNAQJX-CIQKOQMRSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC=C(C=C1)C1=CC=CC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC=C(C=C1)C1=CC=CC=C1)N VUIRXWAMPNAQJX-CIQKOQMRSA-N 0.000 claims 1
- ACWZLISNXFFPNA-CVBNSBKJSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC=CC(=C1)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC=CC(=C1)C)N ACWZLISNXFFPNA-CVBNSBKJSA-N 0.000 claims 1
- NBHCUKOFILUELN-VNHLFDKOSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC=CC(=C1)CC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC=CC(=C1)CC)N NBHCUKOFILUELN-VNHLFDKOSA-N 0.000 claims 1
- WFWDUEJUNGOGMT-PGGGQYKISA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC=CC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC=CC=C1)N WFWDUEJUNGOGMT-PGGGQYKISA-N 0.000 claims 1
- CIDBNJNZUIZTQY-OKAVTEJVSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC=CC=N1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC=CC=N1)N CIDBNJNZUIZTQY-OKAVTEJVSA-N 0.000 claims 1
- DTWYCIYGBSWRKC-LYUQMCDUSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NNC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NNC=C1)N DTWYCIYGBSWRKC-LYUQMCDUSA-N 0.000 claims 1
- DWLHNWRWIUIOGC-LYUQMCDUSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1CC1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1CC1)N DWLHNWRWIUIOGC-LYUQMCDUSA-N 0.000 claims 1
- VVIPZOYQZOOIQL-CVBNSBKJSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1CCCCC1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1CCCCC1)N VVIPZOYQZOOIQL-CVBNSBKJSA-N 0.000 claims 1
- YXSJBPIKWVMZHF-CZEDARRBSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC=1C=C2C=C(NC2=CC=1)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC=1C=C2C=C(NC2=CC=1)C)N YXSJBPIKWVMZHF-CZEDARRBSA-N 0.000 claims 1
- NEZANCRECKEOOF-LEWLWEGZSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC=1C=C2C=CNC2=CC=1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC=1C=C2C=CNC2=CC=1)N NEZANCRECKEOOF-LEWLWEGZSA-N 0.000 claims 1
- UTWNZJDYXNECTA-UYJZDEDHSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC=1C=C2CCCC2=CC=1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC=1C=C2CCCC2=CC=1)N UTWNZJDYXNECTA-UYJZDEDHSA-N 0.000 claims 1
- QHVIULMTULAMBC-OEVKCDGTSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC=1C=CC2=C(N=C(S2)C)C=1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC=1C=CC2=C(N=C(S2)C)C=1)N QHVIULMTULAMBC-OEVKCDGTSA-N 0.000 claims 1
- SAVFNWGBRBONEL-CZEDARRBSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC=1C=NC2=CC=CC=C2C=1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC=1C=NC2=CC=CC=C2C=1)N SAVFNWGBRBONEL-CZEDARRBSA-N 0.000 claims 1
- MMMMWRRJENMDGR-PGGGQYKISA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC=1C=NC=CC=1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC=1C=NC=CC=1)N MMMMWRRJENMDGR-PGGGQYKISA-N 0.000 claims 1
- MZPVSIQNLKMBGY-DNRFBHIXSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCC)N MZPVSIQNLKMBGY-DNRFBHIXSA-N 0.000 claims 1
- CYUHRSMECOIMRJ-JGKZKGBNSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCC1=CC(=CC=C1)Cl)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCC1=CC(=CC=C1)Cl)N CYUHRSMECOIMRJ-JGKZKGBNSA-N 0.000 claims 1
- ZNFOQQXVJKGSJT-JGKZKGBNSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCC1=CC=C(C=C1)Cl)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCC1=CC=C(C=C1)Cl)N ZNFOQQXVJKGSJT-JGKZKGBNSA-N 0.000 claims 1
- CRZRZRWADNRRIN-SKIQCWHVSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCC1=CC=C(C=C1)OC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCC1=CC=C(C=C1)OC)N CRZRZRWADNRRIN-SKIQCWHVSA-N 0.000 claims 1
- FHSCXWYBVBVRNP-DBTMUERSSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCC1=CC=CC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCC1=CC=CC=C1)N FHSCXWYBVBVRNP-DBTMUERSSA-N 0.000 claims 1
- LNWCTICOZMUFIA-RRNIMWOJSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCC1CC1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCC1CC1)N LNWCTICOZMUFIA-RRNIMWOJSA-N 0.000 claims 1
- LODWKRGRVZFBNI-DBTMUERSSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCC1CCCCC1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCC1CCCCC1)N LODWKRGRVZFBNI-DBTMUERSSA-N 0.000 claims 1
- WANDZHHOFWBCQO-KDMJMNFUSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCCC(C)C)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCCC(C)C)N WANDZHHOFWBCQO-KDMJMNFUSA-N 0.000 claims 1
- PEXKSHZXBFHQNZ-QWJAPKFZSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCCC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCCC)N PEXKSHZXBFHQNZ-QWJAPKFZSA-N 0.000 claims 1
- WPNUHOWPFZFXDD-UYJZDEDHSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCCC1=CC=C(C=C1)OC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCCC1=CC=C(C=C1)OC)N WPNUHOWPFZFXDD-UYJZDEDHSA-N 0.000 claims 1
- ACFOIAGSJMBWHL-IWZNKUOBSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCCC1=CC=CC=C1)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCCC1=CC=CC=C1)N ACFOIAGSJMBWHL-IWZNKUOBSA-N 0.000 claims 1
- VPQYEKMWZUSMDP-QWJAPKFZSA-N N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCCOC)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NCCOC)N VPQYEKMWZUSMDP-QWJAPKFZSA-N 0.000 claims 1
- LLDCIYUKRJKWTJ-FDTIFPJHSA-N N[C@@H]1CC[C@H](CC1)C1(NC=2N(C(=N1)NC1=CC=C(C=C1)OCC)N=CC=2)N Chemical compound N[C@@H]1CC[C@H](CC1)C1(NC=2N(C(=N1)NC1=CC=C(C=C1)OCC)N=CC=2)N LLDCIYUKRJKWTJ-FDTIFPJHSA-N 0.000 claims 1
- ZCSGJAIKSQWCTI-NYTJIUQPSA-N N[C@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)C)C)N Chemical compound N[C@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)C)C)N ZCSGJAIKSQWCTI-NYTJIUQPSA-N 0.000 claims 1
- KTCGSOHAQRQYQG-FSWDVZBNSA-N N[C@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)F)C)N Chemical compound N[C@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=C(C=CC=C1)F)C)N KTCGSOHAQRQYQG-FSWDVZBNSA-N 0.000 claims 1
- PALBPIZKZBAGCW-GWTOYCKXSA-N N[C@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)C)N Chemical compound N[C@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)C)N PALBPIZKZBAGCW-GWTOYCKXSA-N 0.000 claims 1
- OTGBKQRZQSOPSC-NJEHHLDASA-N N[C@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)C1=CC=CC=C1)N Chemical compound N[C@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)C1=CC=CC=C1)N OTGBKQRZQSOPSC-NJEHHLDASA-N 0.000 claims 1
- BEIWDVYGHWPNRP-RTHVDDQRSA-N N[C@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=CC=C1)C)N Chemical compound N[C@H]1CC[C@H](CC1)C1(C(=C(C=2N(N1)C=CN=2)NC1=CC=CC=C1)C)N BEIWDVYGHWPNRP-RTHVDDQRSA-N 0.000 claims 1
- LHHNVACGOMAYAU-NYTJIUQPSA-N N[C@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=C(C=C1)C)C)N Chemical compound N[C@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC(=C(C=C1)C)C)N LHHNVACGOMAYAU-NYTJIUQPSA-N 0.000 claims 1
- HWCIBUNZNBVAIM-NHJWOMDBSA-N N[C@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C(=O)N1CCOCC1)N Chemical compound N[C@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C(=O)N1CCOCC1)N HWCIBUNZNBVAIM-NHJWOMDBSA-N 0.000 claims 1
- UFJPJJXAHOSMCF-RTHVDDQRSA-N N[C@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C)N Chemical compound N[C@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)C)N UFJPJJXAHOSMCF-RTHVDDQRSA-N 0.000 claims 1
- HFXXHRRHJVEWFW-GWTOYCKXSA-N N[C@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N1N=CC=C1)N Chemical compound N[C@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)N1N=CC=C1)N HFXXHRRHJVEWFW-GWTOYCKXSA-N 0.000 claims 1
- LNOQGPGGSBBMDD-DBIVSCPCSA-N N[C@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)N Chemical compound N[C@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=C(C=C1)OCC)N LNOQGPGGSBBMDD-DBIVSCPCSA-N 0.000 claims 1
- CUWNJBPRURJXKO-UUVAVEHKSA-N N[C@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=CC=C1)N Chemical compound N[C@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=CC=CC=C1)N CUWNJBPRURJXKO-UUVAVEHKSA-N 0.000 claims 1
- RQLNPAQKYIPXMQ-RTHVDDQRSA-N N[C@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC(=CC(=C1)C)C)N Chemical compound N[C@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC(=CC(=C1)C)C)N RQLNPAQKYIPXMQ-RTHVDDQRSA-N 0.000 claims 1
- DLRQPFZFVKERIS-UUVAVEHKSA-N N[C@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC=C(C=C1)C)N Chemical compound N[C@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC=C(C=C1)C)N DLRQPFZFVKERIS-UUVAVEHKSA-N 0.000 claims 1
- VUIRXWAMPNAQJX-LIMIJEPZSA-N N[C@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC=C(C=C1)C1=CC=CC=C1)N Chemical compound N[C@H]1CC[C@H](CC1)C1(C=C(C=2N(N1)C=CN=2)NC1=NC=C(C=C1)C1=CC=CC=C1)N VUIRXWAMPNAQJX-LIMIJEPZSA-N 0.000 claims 1
- 206010029113 Neovascularisation Diseases 0.000 claims 1
- LDOOKDCZAMMTNL-HDJSIYSDSA-N OC1=CC(S(=O)(=O)N(C)C)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 Chemical compound OC1=CC(S(=O)(=O)N(C)C)=CC=C1NC1=CC(N[C@@H]2CC[C@@H](N)CC2)=NN2C1=NC=C2 LDOOKDCZAMMTNL-HDJSIYSDSA-N 0.000 claims 1
- 206010030113 Oedema Diseases 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 206010033645 Pancreatitis Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 206010035664 Pneumonia Diseases 0.000 claims 1
- 208000033464 Reiter syndrome Diseases 0.000 claims 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 1
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 206010040047 Sepsis Diseases 0.000 claims 1
- 201000010001 Silicosis Diseases 0.000 claims 1
- 108090000190 Thrombin Proteins 0.000 claims 1
- 208000007536 Thrombosis Diseases 0.000 claims 1
- 206010043781 Thyroiditis chronic Diseases 0.000 claims 1
- 206010044248 Toxic shock syndrome Diseases 0.000 claims 1
- 231100000650 Toxic shock syndrome Toxicity 0.000 claims 1
- 206010048873 Traumatic arthritis Diseases 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims 1
- 231100000354 acute hepatitis Toxicity 0.000 claims 1
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 claims 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 230000036592 analgesia Effects 0.000 claims 1
- 208000007502 anemia Diseases 0.000 claims 1
- 230000002491 angiogenic effect Effects 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 230000001363 autoimmune Effects 0.000 claims 1
- 201000005000 autoimmune gastritis Diseases 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 1
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 claims 1
- 208000019664 bone resorption disease Diseases 0.000 claims 1
- 125000005392 carboxamide group Chemical group NC(=O)* 0.000 claims 1
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 1
- 208000001763 cytomegalovirus retinitis Diseases 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 125000005959 diazepanyl group Chemical group 0.000 claims 1
- 208000001848 dysentery Diseases 0.000 claims 1
- 239000002158 endotoxin Substances 0.000 claims 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 231100000869 headache Toxicity 0.000 claims 1
- 201000011066 hemangioma Diseases 0.000 claims 1
- 230000008588 hemolysis Effects 0.000 claims 1
- 231100000283 hepatitis Toxicity 0.000 claims 1
- 208000005252 hepatitis A Diseases 0.000 claims 1
- 208000002672 hepatitis B Diseases 0.000 claims 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 230000007954 hypoxia Effects 0.000 claims 1
- RLUCSSCKYNNVPJ-UHFFFAOYSA-N imidazo[2,1-f][1,2,4]triazine-2,4-diamine Chemical compound N1=C(N)N=C(N)C2=NC=CN21 RLUCSSCKYNNVPJ-UHFFFAOYSA-N 0.000 claims 1
- 230000007813 immunodeficiency Effects 0.000 claims 1
- 230000008595 infiltration Effects 0.000 claims 1
- 238000001764 infiltration Methods 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 206010022000 influenza Diseases 0.000 claims 1
- 208000028867 ischemia Diseases 0.000 claims 1
- 208000012947 ischemia reperfusion injury Diseases 0.000 claims 1
- 208000011379 keloid formation Diseases 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 208000021039 metastatic melanoma Diseases 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 206010028417 myasthenia gravis Diseases 0.000 claims 1
- IMLYCDDHRGSPLB-UHFFFAOYSA-N n-(4-ethoxyphenyl)-6-(4-methyl-1,4-diazepan-1-yl)imidazo[1,2-b]pyridazin-8-amine Chemical compound C1=CC(OCC)=CC=C1NC1=CC(N2CCN(C)CCC2)=NN2C1=NC=C2 IMLYCDDHRGSPLB-UHFFFAOYSA-N 0.000 claims 1
- NHTAVTVNYODDFM-UHFFFAOYSA-N n-(4-ethoxyphenyl)-6-piperazin-1-ylimidazo[1,2-b]pyridazin-8-amine Chemical compound C1=CC(OCC)=CC=C1NC1=CC(N2CCNCC2)=NN2C1=NC=C2 NHTAVTVNYODDFM-UHFFFAOYSA-N 0.000 claims 1
- ZEFXEMXDNDQMQX-UHFFFAOYSA-N n-[4-[(6-chloroimidazo[1,2-b]pyridazin-8-yl)amino]phenyl]-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(C(=O)NC=2C=CC(NC=3C4=NC=CN4N=C(Cl)C=3)=CC=2)=CC=C1 ZEFXEMXDNDQMQX-UHFFFAOYSA-N 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 230000002232 neuromuscular Effects 0.000 claims 1
- 210000000440 neutrophil Anatomy 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 230000010412 perfusion Effects 0.000 claims 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 150000003180 prostaglandins Chemical class 0.000 claims 1
- 201000003651 pulmonary sarcoidosis Diseases 0.000 claims 1
- 125000002098 pyridazinyl group Chemical group 0.000 claims 1
- 208000002574 reactive arthritis Diseases 0.000 claims 1
- 201000005404 rubella Diseases 0.000 claims 1
- 231100000241 scar Toxicity 0.000 claims 1
- 230000036303 septic shock Effects 0.000 claims 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
- 125000003831 tetrazolyl group Chemical group 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 230000008719 thickening Effects 0.000 claims 1
- 229960004072 thrombin Drugs 0.000 claims 1
- 206010043554 thrombocytopenia Diseases 0.000 claims 1
- 230000009772 tissue formation Effects 0.000 claims 1
- 208000004371 toothache Diseases 0.000 claims 1
- 230000008733 trauma Effects 0.000 claims 1
- 125000001425 triazolyl group Chemical group 0.000 claims 1
- 201000008827 tuberculosis Diseases 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
- 0 *NC(CCCC1)C1N Chemical compound *NC(CCCC1)C1N 0.000 description 20
- PEUGKEHLRUVPAN-UHFFFAOYSA-N NC1CNCCC1 Chemical compound NC1CNCCC1 PEUGKEHLRUVPAN-UHFFFAOYSA-N 0.000 description 3
- VKIRRGRTJUUZHS-UHFFFAOYSA-N NC(CC1)CCC1N Chemical compound NC(CC1)CCC1N VKIRRGRTJUUZHS-UHFFFAOYSA-N 0.000 description 2
- DZIHTWJGPDVSGE-UHFFFAOYSA-N NC1CCC(CC(CC2)CCC2N)CC1 Chemical compound NC1CCC(CC(CC2)CCC2N)CC1 DZIHTWJGPDVSGE-UHFFFAOYSA-N 0.000 description 2
- NGXSWUFDCSEIOO-UHFFFAOYSA-N NC1CNCC1 Chemical compound NC1CNCC1 NGXSWUFDCSEIOO-UHFFFAOYSA-N 0.000 description 2
- OISZIRHDSSOUKW-UHFFFAOYSA-N Nc(cc1)ccc1NC(Nc1ccccc1)=O Chemical compound Nc(cc1)ccc1NC(Nc1ccccc1)=O OISZIRHDSSOUKW-UHFFFAOYSA-N 0.000 description 2
- CWLKGDAVCFYWJK-UHFFFAOYSA-N Nc1cc(O)ccc1 Chemical compound Nc1cc(O)ccc1 CWLKGDAVCFYWJK-UHFFFAOYSA-N 0.000 description 2
- SDHOUBKWHPJTLD-UHFFFAOYSA-N C/C=S(\c(c(-c1c(-c(cc2)ccc2N)nc(C)[s]1)c1)cc(O)c1N)/N(C)C Chemical compound C/C=S(\c(c(-c1c(-c(cc2)ccc2N)nc(C)[s]1)c1)cc(O)c1N)/N(C)C SDHOUBKWHPJTLD-UHFFFAOYSA-N 0.000 description 1
- QMGBIPKOKCSUCL-UHFFFAOYSA-N CC(C)Oc1cccc(N)c1 Chemical compound CC(C)Oc1cccc(N)c1 QMGBIPKOKCSUCL-UHFFFAOYSA-N 0.000 description 1
- CHMBIJAOCISYEW-UHFFFAOYSA-N CC(Nc(cc1)ccc1N)=O Chemical compound CC(Nc(cc1)ccc1N)=O CHMBIJAOCISYEW-UHFFFAOYSA-N 0.000 description 1
- UBRIHZOFEJHMIT-UHFFFAOYSA-N CCCCOc(cc1)ccc1N Chemical compound CCCCOc(cc1)ccc1N UBRIHZOFEJHMIT-UHFFFAOYSA-N 0.000 description 1
- PEDHCXVSNZZLSR-UHFFFAOYSA-N CCCNS(c(cc1)ccc1N)(=O)=O Chemical compound CCCNS(c(cc1)ccc1N)(=O)=O PEDHCXVSNZZLSR-UHFFFAOYSA-N 0.000 description 1
- RNVOPVJRSRXPSX-UHFFFAOYSA-N CCN(CC)C(c(cc1)ccc1N)=O Chemical compound CCN(CC)C(c(cc1)ccc1N)=O RNVOPVJRSRXPSX-UHFFFAOYSA-N 0.000 description 1
- PECCRTHITMTOJM-UHFFFAOYSA-N CCN(CC)C(c1cccc(N)c1)=O Chemical compound CCN(CC)C(c1cccc(N)c1)=O PECCRTHITMTOJM-UHFFFAOYSA-N 0.000 description 1
- AJBNWRTYIGBFFO-UHFFFAOYSA-N CCN(CC[O]=S(c(cc1)ccc1N)(NC)=O)S(c(cc1)ccc1N)(=O)=O Chemical compound CCN(CC[O]=S(c(cc1)ccc1N)(NC)=O)S(c(cc1)ccc1N)(=O)=O AJBNWRTYIGBFFO-UHFFFAOYSA-N 0.000 description 1
- FDZPXCJOUIWRII-UHFFFAOYSA-N CCNS(c(cc1)ccc1N)(=O)=O Chemical compound CCNS(c(cc1)ccc1N)(=O)=O FDZPXCJOUIWRII-UHFFFAOYSA-N 0.000 description 1
- XHJVWDBSIBURKF-UHFFFAOYSA-N CC[n]1nnc(-c(cc2)ccc2N)n1 Chemical compound CC[n]1nnc(-c(cc2)ccc2N)n1 XHJVWDBSIBURKF-UHFFFAOYSA-N 0.000 description 1
- GMJMGFSEWNBTQS-UHFFFAOYSA-N CCc(cc(cc1)N)c1NC(C1=CC=CN(c(cc2)ccc2F)C1=O)=O Chemical compound CCc(cc(cc1)N)c1NC(C1=CC=CN(c(cc2)ccc2F)C1=O)=O GMJMGFSEWNBTQS-UHFFFAOYSA-N 0.000 description 1
- SJWHILBZPGQBJE-UHFFFAOYSA-N CCc1cc(N)ncc1 Chemical compound CCc1cc(N)ncc1 SJWHILBZPGQBJE-UHFFFAOYSA-N 0.000 description 1
- OUQDABOHCJPODN-UHFFFAOYSA-N CN(C)C(CC1)CN1c(ccc(N)c1)c1-c1cc(S(N(C)c2ccccc2)(=O)=O)cc(N)c1 Chemical compound CN(C)C(CC1)CN1c(ccc(N)c1)c1-c1cc(S(N(C)c2ccccc2)(=O)=O)cc(N)c1 OUQDABOHCJPODN-UHFFFAOYSA-N 0.000 description 1
- QEPGWLBMAAEBCP-UHFFFAOYSA-N CN(C)C(c(cc1)ccc1N)=O Chemical compound CN(C)C(c(cc1)ccc1N)=O QEPGWLBMAAEBCP-UHFFFAOYSA-N 0.000 description 1
- IAFBZKJXDYDYEC-UHFFFAOYSA-N CN(C)S(c(ccc(N)c1)c1O)(=O)=O Chemical compound CN(C)S(c(ccc(N)c1)c1O)(=O)=O IAFBZKJXDYDYEC-UHFFFAOYSA-N 0.000 description 1
- APIVVDFBBPFBDZ-UHFFFAOYSA-N CN(C)S(c1cccc(N)c1)(=O)=O Chemical compound CN(C)S(c1cccc(N)c1)(=O)=O APIVVDFBBPFBDZ-UHFFFAOYSA-N 0.000 description 1
- AZVALGVPGMRBBB-UHFFFAOYSA-N CN(CCc1ncccc1)C(c(cc1)ccc1N)=O Chemical compound CN(CCc1ncccc1)C(c(cc1)ccc1N)=O AZVALGVPGMRBBB-UHFFFAOYSA-N 0.000 description 1
- FXHRAKUEZPSMLJ-UHFFFAOYSA-N CN1CCNCCC1 Chemical compound CN1CCNCCC1 FXHRAKUEZPSMLJ-UHFFFAOYSA-N 0.000 description 1
- OUJYKUHSXQGQFH-UHFFFAOYSA-N COc(ccc(CCN)c1)c1[F]c1cccc(F)c1N Chemical compound COc(ccc(CCN)c1)c1[F]c1cccc(F)c1N OUJYKUHSXQGQFH-UHFFFAOYSA-N 0.000 description 1
- WVEFNAWDWIDKIQ-UHFFFAOYSA-N COc1cc(NC(c(cc2)ccc2N)=O)ccc1 Chemical compound COc1cc(NC(c(cc2)ccc2N)=O)ccc1 WVEFNAWDWIDKIQ-UHFFFAOYSA-N 0.000 description 1
- IDPURXSQCKYKIJ-UHFFFAOYSA-N COc1ccc(CN)cc1 Chemical compound COc1ccc(CN)cc1 IDPURXSQCKYKIJ-UHFFFAOYSA-N 0.000 description 1
- NCBZRJODKRCREW-UHFFFAOYSA-N COc1cccc(N)c1 Chemical compound COc1cccc(N)c1 NCBZRJODKRCREW-UHFFFAOYSA-N 0.000 description 1
- FUZWWFVYRMIXMT-UHFFFAOYSA-N C[n]1c(-c(cc2)ccc2N)nnc1 Chemical compound C[n]1c(-c(cc2)ccc2N)nnc1 FUZWWFVYRMIXMT-UHFFFAOYSA-N 0.000 description 1
- OIYCOGMOLXTCIX-UHFFFAOYSA-N C[n]1nccc1NC(c(cc1)ccc1N)=O Chemical compound C[n]1nccc1NC(c(cc1)ccc1N)=O OIYCOGMOLXTCIX-UHFFFAOYSA-N 0.000 description 1
- JBCDCYFEJQHTTA-UHFFFAOYSA-N Cc(c(C(F)(F)F)c1)ccc1N Chemical compound Cc(c(C(F)(F)F)c1)ccc1N JBCDCYFEJQHTTA-UHFFFAOYSA-N 0.000 description 1
- MGRHBBRSAFPBIN-UHFFFAOYSA-N Cc(c(F)c1)ccc1N Chemical compound Cc(c(F)c1)ccc1N MGRHBBRSAFPBIN-UHFFFAOYSA-N 0.000 description 1
- HIHCTGNZNHSZPP-UHFFFAOYSA-N Cc(cc(cc1)N)c1Cl Chemical compound Cc(cc(cc1)N)c1Cl HIHCTGNZNHSZPP-UHFFFAOYSA-N 0.000 description 1
- ZQEXBVHABAJPHJ-UHFFFAOYSA-N Cc(cc1)cc(F)c1N Chemical compound Cc(cc1)cc(F)c1N ZQEXBVHABAJPHJ-UHFFFAOYSA-N 0.000 description 1
- RNVCVTLRINQCPJ-UHFFFAOYSA-N Cc(cccc1)c1N Chemical compound Cc(cccc1)c1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 1
- NYMDPDNETOLVBS-UHFFFAOYSA-N Cc1cc(N)ccc1F Chemical compound Cc1cc(N)ccc1F NYMDPDNETOLVBS-UHFFFAOYSA-N 0.000 description 1
- GNCLPNMQEGMNTG-UHFFFAOYSA-N Cc1cc(N)ccn1 Chemical compound Cc1cc(N)ccn1 GNCLPNMQEGMNTG-UHFFFAOYSA-N 0.000 description 1
- BBIJFGCYKOQACJ-UHFFFAOYSA-N Cc1ccc(-c(cc2)ccc2N)[o]1 Chemical compound Cc1ccc(-c(cc2)ccc2N)[o]1 BBIJFGCYKOQACJ-UHFFFAOYSA-N 0.000 description 1
- VCEXBZCDUSJIFF-UHFFFAOYSA-N NC(CC1)(CC2)CCC12N Chemical compound NC(CC1)(CC2)CCC12N VCEXBZCDUSJIFF-UHFFFAOYSA-N 0.000 description 1
- ZQWRZCZEOLZBQF-UHFFFAOYSA-N NC(CC1)CC1N Chemical compound NC(CC1)CC1N ZQWRZCZEOLZBQF-UHFFFAOYSA-N 0.000 description 1
- XXNHZBQAIOYZJK-UHFFFAOYSA-N NC(CC1)CCC1Nc1ccnc(Cl)n1 Chemical compound NC(CC1)CCC1Nc1ccnc(Cl)n1 XXNHZBQAIOYZJK-UHFFFAOYSA-N 0.000 description 1
- LUBJCRLGQSPQNN-UHFFFAOYSA-N NC(Nc1ccccc1)=O Chemical compound NC(Nc1ccccc1)=O LUBJCRLGQSPQNN-UHFFFAOYSA-N 0.000 description 1
- PAFZNILMFXTMIY-UHFFFAOYSA-N NC1CCCCC1 Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 1
- BCIIMDOZSUCSEN-UHFFFAOYSA-N NC1CCNCC1 Chemical compound NC1CCNCC1 BCIIMDOZSUCSEN-UHFFFAOYSA-N 0.000 description 1
- IPOVLZSJBYKHHU-UHFFFAOYSA-N NCC1CNCCC1 Chemical compound NCC1CNCCC1 IPOVLZSJBYKHHU-UHFFFAOYSA-N 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N NCCc1ccccc1 Chemical compound NCCc1ccccc1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- YMVFJGSXZNNUDW-UHFFFAOYSA-N NCc(cc1)ccc1Cl Chemical compound NCc(cc1)ccc1Cl YMVFJGSXZNNUDW-UHFFFAOYSA-N 0.000 description 1
- BJFPYGGTDAYECS-UHFFFAOYSA-N NCc1cc(Cl)ccc1 Chemical compound NCc1cc(Cl)ccc1 BJFPYGGTDAYECS-UHFFFAOYSA-N 0.000 description 1
- DDRPCXLAQZKBJP-UHFFFAOYSA-N NCc1ccc[o]1 Chemical compound NCc1ccc[o]1 DDRPCXLAQZKBJP-UHFFFAOYSA-N 0.000 description 1
- ZCBIFHNDZBSCEP-UHFFFAOYSA-N Nc(cc1)cc2c1[nH]cc2 Chemical compound Nc(cc1)cc2c1[nH]cc2 ZCBIFHNDZBSCEP-UHFFFAOYSA-N 0.000 description 1
- BPNGSEJDRLWEPM-UHFFFAOYSA-N Nc(cc1)ccc1-[n](cn1)c(Cl)c1Cl Chemical compound Nc(cc1)ccc1-[n](cn1)c(Cl)c1Cl BPNGSEJDRLWEPM-UHFFFAOYSA-N 0.000 description 1
- LVOASPZGXNAHJI-UHFFFAOYSA-N Nc(cc1)ccc1-[n]1cncc1 Chemical compound Nc(cc1)ccc1-[n]1cncc1 LVOASPZGXNAHJI-UHFFFAOYSA-N 0.000 description 1
- CSFIQHZIFKIQNO-UHFFFAOYSA-N Nc(cc1)ccc1-[n]1nccc1 Chemical compound Nc(cc1)ccc1-[n]1nccc1 CSFIQHZIFKIQNO-UHFFFAOYSA-N 0.000 description 1
- BLNPEJXSNSBBNM-UHFFFAOYSA-N Nc(cc1)ccc1-[n]1ncnc1 Chemical compound Nc(cc1)ccc1-[n]1ncnc1 BLNPEJXSNSBBNM-UHFFFAOYSA-N 0.000 description 1
- YBAZINRZQSAIAY-UHFFFAOYSA-N Nc(cc1)ccc1C#N Chemical compound Nc(cc1)ccc1C#N YBAZINRZQSAIAY-UHFFFAOYSA-N 0.000 description 1
- YUSYBNPRLWNZLL-UHFFFAOYSA-N Nc(cc1)ccc1C(N(CC1)CCC1c1ccccc1)=O Chemical compound Nc(cc1)ccc1C(N(CC1)CCC1c1ccccc1)=O YUSYBNPRLWNZLL-UHFFFAOYSA-N 0.000 description 1
- FQEGZNLIOFLYNI-UHFFFAOYSA-N Nc(cc1)ccc1C(N1CCCCC1)=O Chemical compound Nc(cc1)ccc1C(N1CCCCC1)=O FQEGZNLIOFLYNI-UHFFFAOYSA-N 0.000 description 1
- WEHVQIQNGXWTME-UHFFFAOYSA-N Nc(cc1)ccc1C(N1CCOCC1)=O Chemical compound Nc(cc1)ccc1C(N1CCOCC1)=O WEHVQIQNGXWTME-UHFFFAOYSA-N 0.000 description 1
- QWDWYVRAIBAAKD-UHFFFAOYSA-N Nc(cc1)ccc1C(NC1=CC=CN(c(cc2)ccc2F)C1=O)=O Chemical compound Nc(cc1)ccc1C(NC1=CC=CN(c(cc2)ccc2F)C1=O)=O QWDWYVRAIBAAKD-UHFFFAOYSA-N 0.000 description 1
- TZPIKGCQLFRHGR-UHFFFAOYSA-N Nc(cc1)ccc1C(NC1CC1)=O Chemical compound Nc(cc1)ccc1C(NC1CC1)=O TZPIKGCQLFRHGR-UHFFFAOYSA-N 0.000 description 1
- KAESCVXWIWIQKP-UHFFFAOYSA-N Nc(cc1)ccc1C(NC1CCCCC1)=O Chemical compound Nc(cc1)ccc1C(NC1CCCCC1)=O KAESCVXWIWIQKP-UHFFFAOYSA-N 0.000 description 1
- JDOKXFXURKWJTP-UHFFFAOYSA-N Nc(cc1)ccc1C(NCC1CCCCC1)=O Chemical compound Nc(cc1)ccc1C(NCC1CCCCC1)=O JDOKXFXURKWJTP-UHFFFAOYSA-N 0.000 description 1
- TZZWJFFYJXELAI-UHFFFAOYSA-N Nc(cc1)ccc1C(NCCCN(CCC1)C1=O)=O Chemical compound Nc(cc1)ccc1C(NCCCN(CCC1)C1=O)=O TZZWJFFYJXELAI-UHFFFAOYSA-N 0.000 description 1
- YECHMIOBPCMIGF-UHFFFAOYSA-N Nc(cc1)ccc1C(NCCO)=O Chemical compound Nc(cc1)ccc1C(NCCO)=O YECHMIOBPCMIGF-UHFFFAOYSA-N 0.000 description 1
- ZWMQLNXGNSNUEO-UHFFFAOYSA-N Nc(cc1)ccc1C(NCc1ccccc1)=O Chemical compound Nc(cc1)ccc1C(NCc1ccccc1)=O ZWMQLNXGNSNUEO-UHFFFAOYSA-N 0.000 description 1
- QAGZEYSYZCLCSG-UHFFFAOYSA-N Nc(cc1)ccc1C(NCc1ccncc1)=O Chemical compound Nc(cc1)ccc1C(NCc1ccncc1)=O QAGZEYSYZCLCSG-UHFFFAOYSA-N 0.000 description 1
- QHWDUJPWCGEBTH-UHFFFAOYSA-N Nc(cc1)ccc1C(Nc1ccccc1)=O Chemical compound Nc(cc1)ccc1C(Nc1ccccc1)=O QHWDUJPWCGEBTH-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N Nc(cc1)ccc1C(O)=O Chemical compound Nc(cc1)ccc1C(O)=O ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- CBCKQZAAMUWICA-UHFFFAOYSA-N Nc(cc1)ccc1N Chemical compound Nc(cc1)ccc1N CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 1
- UNJGYYYQHKBWCZ-UHFFFAOYSA-N Nc(cc1)ccc1NC(C1=CC=CN(c(cc2)ccc2F)C1=O)=O Chemical compound Nc(cc1)ccc1NC(C1=CC=CN(c(cc2)ccc2F)C1=O)=O UNJGYYYQHKBWCZ-UHFFFAOYSA-N 0.000 description 1
- GTTFJYUWPUKXJH-UHFFFAOYSA-N Nc(cc1)ccc1NC(c1ccccc1)=O Chemical compound Nc(cc1)ccc1NC(c1ccccc1)=O GTTFJYUWPUKXJH-UHFFFAOYSA-N 0.000 description 1
- ZSAJBXJTPPOFEX-UHFFFAOYSA-N Nc(cc1)ccc1NS=O Chemical compound Nc(cc1)ccc1NS=O ZSAJBXJTPPOFEX-UHFFFAOYSA-N 0.000 description 1
- PLIKAWJENQZMHA-UHFFFAOYSA-N Nc(cc1)ccc1O Chemical compound Nc(cc1)ccc1O PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N Nc(cc1)ccc1S(N)(=O)=O Chemical compound Nc(cc1)ccc1S(N)(=O)=O FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- JTIWXDLCUZTDFM-UHFFFAOYSA-N Nc(cc1)ccc1S(N1CCCC1)(=O)=O Chemical compound Nc(cc1)ccc1S(N1CCCC1)(=O)=O JTIWXDLCUZTDFM-UHFFFAOYSA-N 0.000 description 1
- HVBSAKJJOYLTQU-UHFFFAOYSA-N Nc(cc1)ccc1S(O)(=O)=O Chemical compound Nc(cc1)ccc1S(O)(=O)=O HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 1
- OAPVIBHQRYFYSE-UHFFFAOYSA-N Nc(cc1)ncc1-c1ccccc1 Chemical compound Nc(cc1)ncc1-c1ccccc1 OAPVIBHQRYFYSE-UHFFFAOYSA-N 0.000 description 1
- CDAWCLOXVUBKRW-UHFFFAOYSA-N Nc(cccc1)c1O Chemical compound Nc(cccc1)c1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 1
- NJXPYZHXZZCTNI-UHFFFAOYSA-N Nc1cc(C#N)ccc1 Chemical compound Nc1cc(C#N)ccc1 NJXPYZHXZZCTNI-UHFFFAOYSA-N 0.000 description 1
- IGPFOKFDBICQMC-UHFFFAOYSA-N Nc1cc(OCc2ccccc2)ccc1 Chemical compound Nc1cc(OCc2ccccc2)ccc1 IGPFOKFDBICQMC-UHFFFAOYSA-N 0.000 description 1
- FKFOJDYRQYJURJ-UHFFFAOYSA-N Nc1cc(S(N2CCOCC2)(=O)=O)ccc1 Chemical compound Nc1cc(S(N2CCOCC2)(=O)=O)ccc1 FKFOJDYRQYJURJ-UHFFFAOYSA-N 0.000 description 1
- XFDUHJPVQKIXHO-UHFFFAOYSA-N Nc1cccc(C(O)=O)c1 Chemical compound Nc1cccc(C(O)=O)c1 XFDUHJPVQKIXHO-UHFFFAOYSA-N 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Nc1ccccc1 Chemical compound Nc1ccccc1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- JVVRJMXHNUAPHW-UHFFFAOYSA-N Nc1n[nH]cc1 Chemical compound Nc1n[nH]cc1 JVVRJMXHNUAPHW-UHFFFAOYSA-N 0.000 description 1
- LDSQQXKSEFZAPE-UHFFFAOYSA-N OCCC1CCNCC1 Chemical compound OCCC1CCNCC1 LDSQQXKSEFZAPE-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71951905P | 2005-09-22 | 2005-09-22 | |
| US60/719,519 | 2005-09-22 | ||
| US11/524,996 | 2006-09-21 | ||
| US11/524,996 US20070078136A1 (en) | 2005-09-22 | 2006-09-21 | Fused heterocyclic compounds useful as kinase modulators |
| PCT/US2006/037056 WO2007038314A2 (en) | 2005-09-22 | 2006-09-22 | Fused heterocyclic compounds useful as kinase modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009509961A JP2009509961A (ja) | 2009-03-12 |
| JP2009509961A5 true JP2009509961A5 (https=) | 2009-10-22 |
| JP5241498B2 JP5241498B2 (ja) | 2013-07-17 |
Family
ID=37716206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008532430A Expired - Fee Related JP5241498B2 (ja) | 2005-09-22 | 2006-09-22 | キナーゼモジュレーターとして有用な縮合へテロ環化合物 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20070078136A1 (https=) |
| EP (1) | EP1928879B1 (https=) |
| JP (1) | JP5241498B2 (https=) |
| KR (2) | KR101399766B1 (https=) |
| AR (1) | AR055177A1 (https=) |
| AU (1) | AU2006295439B2 (https=) |
| BR (1) | BRPI0616393B8 (https=) |
| CA (1) | CA2623369C (https=) |
| CY (1) | CY1114001T1 (https=) |
| DK (1) | DK1928879T3 (https=) |
| EA (1) | EA017632B1 (https=) |
| ES (1) | ES2402664T3 (https=) |
| GE (1) | GEP20104943B (https=) |
| HR (1) | HRP20130155T1 (https=) |
| IL (1) | IL190280A (https=) |
| NO (1) | NO20081231L (https=) |
| NZ (1) | NZ566663A (https=) |
| PE (1) | PE20070520A1 (https=) |
| PH (1) | PH12013501329B1 (https=) |
| PL (1) | PL1928879T3 (https=) |
| PT (1) | PT1928879E (https=) |
| SI (1) | SI1928879T1 (https=) |
| TW (2) | TWI478925B (https=) |
| WO (1) | WO2007038314A2 (https=) |
Families Citing this family (131)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20080538A1 (es) | 2006-08-04 | 2008-06-18 | Takeda Pharmaceutical | Derivado heterociclico fusionado y su uso |
| EP2125819B1 (en) * | 2007-03-21 | 2014-10-22 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful for the treatment of proliferative, allergic, autoimmune or inflammatory diseases |
| AR067326A1 (es) * | 2007-05-11 | 2009-10-07 | Novartis Ag | Imidazopiridinas y pirrolo -pirimidinas sustituidas como inhibidores de cinasa de lipido |
| ES2375425T3 (es) * | 2007-07-26 | 2012-02-29 | Novartis Ag | Compuestos org�?nicos. |
| CN101918381A (zh) * | 2007-11-21 | 2010-12-15 | 解码遗传Ehf公司 | 用于治疗肺部和心血管病症的取代苯并唑pde4抑制剂 |
| KR20100098653A (ko) * | 2007-11-21 | 2010-09-08 | 디코드 제네틱스 이에이치에프 | 염증의 치료를 위한 바이아릴 ｐｄｅ４ 억제제 |
| JP5693239B2 (ja) * | 2008-01-23 | 2015-04-01 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | ４−ピリジノン化合物および癌についてのその使用 |
| WO2009100375A1 (en) * | 2008-02-06 | 2009-08-13 | Bristol-Myers Squibb Company | Substituted imidazopyridazines useful as kinase inhibitors |
| PE20091468A1 (es) | 2008-02-28 | 2009-10-22 | Novartis Ag | DERIVADOS DE 3-METIL-IMIDAZO-[1,2-b]-PIRIDAZINA |
| ES2413806T3 (es) * | 2008-03-20 | 2013-07-17 | Amgen Inc. | Moduladores de la aurora cinasa y método de uso |
| WO2009140128A2 (en) * | 2008-05-13 | 2009-11-19 | Irm Llc | Compounds and compositions as kinase inhibitors |
| WO2010036407A2 (en) * | 2008-05-15 | 2010-04-01 | Biocryst Pharmaceuticals, Inc. | Antiviral nucleoside analogs |
| WO2009143211A2 (en) | 2008-05-21 | 2009-11-26 | Incyte Corporation | Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same |
| US8476430B2 (en) * | 2008-07-24 | 2013-07-02 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as kinase modulators |
| UY32049A (es) * | 2008-08-14 | 2010-03-26 | Takeda Pharmaceutical | Inhibidores de cmet |
| WO2010027114A1 (en) * | 2008-09-05 | 2010-03-11 | Choongwae Pharma Corporation | Use of pyrazole-pyridine derivatives and its salts for treating or reventin osteoporosis |
| PT2350075E (pt) | 2008-09-22 | 2014-06-09 | Array Biopharma Inc | Compostos imidazo[1,2b]piridazina substituídos como inibidores da trk cinase |
| TWI491610B (zh) * | 2008-10-09 | 2015-07-11 | 必治妥美雅史谷比公司 | 作為激酶抑制劑之咪唑并嗒腈 |
| AR074052A1 (es) | 2008-10-22 | 2010-12-22 | Array Biopharma Inc | Compuestos pirazolo{1,5-a}pirimidina sustituida como inhibidores de trk cinasa |
| WO2010068810A2 (en) * | 2008-12-10 | 2010-06-17 | Cgi Pharmaceuticals, Inc. | Certain substituted amides, method of making, and method of use thereof |
| PA8854101A1 (es) * | 2008-12-18 | 2010-07-27 | Ortho Mcneil Janssen Pharm | Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa |
| JP5487214B2 (ja) | 2008-12-19 | 2014-05-07 | ブリストル−マイヤーズ スクイブ カンパニー | キナーゼ阻害剤として有用なカルバゾールカルボキシアミド化合物 |
| JP5578490B2 (ja) | 2008-12-26 | 2014-08-27 | 味の素株式会社 | ピラゾロピリミジン化合物 |
| WO2010089292A1 (en) | 2009-02-06 | 2010-08-12 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc | Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators |
| TWI461425B (zh) | 2009-02-19 | 2014-11-21 | Janssen Pharmaceuticals Inc | 作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類 |
| AU2010262036B2 (en) | 2009-05-07 | 2014-10-30 | Cellzome Limited | Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators |
| EP2440204B1 (en) | 2009-06-12 | 2013-12-18 | Bristol-Myers Squibb Company | Nicotinamide compounds useful as kinase modulators |
| AR077468A1 (es) | 2009-07-09 | 2011-08-31 | Array Biopharma Inc | Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa |
| JP2012532912A (ja) | 2009-07-15 | 2012-12-20 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | ガンマセクレターゼモジュレーターとしての置換されたトリアゾールおよびイミダゾール誘導体 |
| US8389526B2 (en) | 2009-08-07 | 2013-03-05 | Novartis Ag | 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives |
| PH12012500778A1 (en) | 2009-10-30 | 2012-11-26 | Janssen Pharmaceutica Nv | IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS |
| WO2011078221A1 (ja) | 2009-12-24 | 2011-06-30 | 味の素株式会社 | イミダゾピリダジン化合物 |
| BR112012017310A2 (pt) | 2010-01-15 | 2016-04-19 | Janssen Pharmaceuticals Inc | derivados de triazol substituídos como moduladores de gama secretase |
| EP2526102B1 (en) | 2010-01-22 | 2017-03-08 | Fundación Centro Nacional de Investigaciones Oncológicas Carlos III | Inhibitors of PI3 kinase |
| AR080754A1 (es) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
| JP5583845B2 (ja) | 2010-04-28 | 2014-09-03 | ブリストル−マイヤーズ スクイブ カンパニー | イミダゾピリダジニル化合物および癌に対するそれらの使用 |
| US20130131057A1 (en) | 2010-05-13 | 2013-05-23 | Centro Nacional De Investigaciones Oncologicas (Cnio | New bicyclic compounds as pi3-k and mtor inhibitors |
| NZ604708A (en) | 2010-05-20 | 2015-05-29 | Array Biopharma Inc | Macrocyclic compounds as trk kinase inhibitors |
| US8685969B2 (en) | 2010-06-16 | 2014-04-01 | Bristol-Myers Squibb Company | Carboline carboxamide compounds useful as kinase inhibitors |
| EP2598505B1 (en) | 2010-07-28 | 2015-03-18 | Bayer Intellectual Property GmbH | Substituted imidazo[1,2-b]pyridazines |
| US8637516B2 (en) | 2010-09-09 | 2014-01-28 | Irm Llc | Compounds and compositions as TRK inhibitors |
| TWI541243B (zh) | 2010-09-10 | 2016-07-11 | 拜耳知識產權公司 | 經取代咪唑并嗒 |
| US9266880B2 (en) | 2010-11-12 | 2016-02-23 | Bristol-Myers Squibb Company | Substituted azaindazole compounds |
| CN103415518A (zh) | 2010-12-17 | 2013-11-27 | 拜耳知识产权有限责任公司 | 在过度增殖性病症的治疗中用作mps-1和tkk抑制剂的咪唑并吡嗪 |
| US9284317B2 (en) | 2010-12-17 | 2016-03-15 | Bayer Intellectual Property Gmbh | Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitors |
| JP5822944B2 (ja) | 2010-12-17 | 2015-11-25 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ | 過剰増殖性障害の治療におけるｍｐｓ−１およびｔｋｋ阻害剤として使用するための２置換イミダゾピラジン |
| AU2012230348A1 (en) | 2011-03-24 | 2013-08-29 | Cellzome Limited | Novel substituted triazolyl piperazine and triazolyl piperidine derivatives as gamma secretase modulators |
| GB201108003D0 (en) | 2011-05-13 | 2011-06-29 | Materialise Dental Nv | Endodontic treatment simulation system |
| CA2836203A1 (en) | 2011-05-17 | 2012-11-22 | Bayer Intellectual Property Gmbh | Amino-substituted imidazopyridazines as mknk1 kinase inhibitors |
| WO2012163942A1 (en) | 2011-06-01 | 2012-12-06 | Bayer Intellectual Property Gmbh | Substituted aminoimidazopyridazines |
| US9284319B2 (en) | 2011-06-22 | 2016-03-15 | Bayer Intellectual Property Gmbh | Heterocyclyl aminoimidazopyridazines |
| BR112013033375B1 (pt) | 2011-06-27 | 2022-05-10 | Janssen Pharmaceutica N.V | Derivados de 1-aril-4-metil-[1,2,4]triazolo[4,3-a]quinoxa-lina, seu uso, composição farmacêutica que os compreende, processo de preparação dos mesmos, solução estéril e composto intermediário |
| KR101913135B1 (ko) | 2011-07-15 | 2018-10-30 | 얀센 파마슈티칼즈, 인코포레이티드 | 감마 세크레타제 조절 인자로서의 신규의 치환 인돌 유도체 |
| WO2013012915A1 (en) | 2011-07-19 | 2013-01-24 | Infinity Pharmaceuticals Inc. | Heterocyclic compounds and uses thereof |
| WO2013041634A1 (en) | 2011-09-23 | 2013-03-28 | Bayer Intellectual Property Gmbh | Substituted imidazopyridazines |
| US8969586B2 (en) | 2011-09-27 | 2015-03-03 | Bristol-Myers Squibb Company | Substituted bicyclic heteroaryl compounds |
| RU2662443C2 (ru) * | 2011-11-01 | 2018-07-26 | Ф. Хоффманн-Ля Рош Аг | Имидазопиридазины |
| WO2013104573A1 (en) | 2012-01-10 | 2013-07-18 | F. Hoffmann-La Roche Ag | Pyridazine amide compounds and their use as syk inhibitors |
| RU2014140739A (ru) | 2012-03-09 | 2016-04-27 | Лексикон Фармасьютикалз, Инк. | Соединения на основе имидазо[1, 2-b]пиридазина, композиции таких соединений и способы их применения |
| CN104284896B (zh) | 2012-03-14 | 2016-06-01 | 拜耳知识产权有限责任公司 | 取代的咪唑并哒嗪 |
| US9181245B2 (en) | 2012-05-16 | 2015-11-10 | Janssen Pharmaceuticals, Inc. | Substituted pyrido[1,2-a]pyrazines and substituted pyrido[1,2-a][1,4]diazepines for the treatment of (inter alia) Alzheimer's disease |
| HK1206250A1 (en) | 2012-06-26 | 2016-01-08 | Janssen Pharmaceutica Nv | Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl-[1,2,4] triazolo [4,3-a] quinoxaline compounds and ped 10 inhibitors for use in the treatment of neurological or metabolic disorders |
| WO2014009305A1 (en) | 2012-07-09 | 2014-01-16 | Janssen Pharmaceutica Nv | Inhibitors of phosphodiesterase 10 enzyme |
| TW201414737A (zh) | 2012-07-13 | 2014-04-16 | 必治妥美雅史谷比公司 | 作爲激酶抑制劑之咪唑并三□甲腈 |
| WO2014020041A1 (en) | 2012-08-02 | 2014-02-06 | Bayer Pharma Aktiengesellschaft | Combinations for the treatment of cancer |
| ES2666353T3 (es) | 2012-09-06 | 2018-05-04 | Bristol-Myers Squibb Company | Inhibidores de JAK3 de imidazopiridazina y su uso para el tratamiento de enfermedades inflamatorias y autoinmunitarias |
| US9573954B2 (en) | 2012-11-16 | 2017-02-21 | University Health Network | Pyrazolopyrimidine compounds |
| CA2889249C (en) | 2012-12-20 | 2021-02-16 | Francois Paul Bischoff | Tricyclic 3,4-dihydro-2h-pyrido[1,2-a]pyrazine-1,6-dione derivatives as gamma secretase modulators |
| EP2935272B1 (en) | 2012-12-21 | 2017-02-22 | Bristol-Myers Squibb Company | Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitors |
| JP6267231B2 (ja) | 2012-12-21 | 2018-01-24 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | カゼインキナーゼ１δ／ε阻害剤としての新規な置換イミダゾール |
| CA2891755C (en) | 2013-01-17 | 2021-10-26 | Janssen Pharmaceutica Nv | Substituted pyrido-piperazinone derivatives as gamma secretase modulators |
| WO2014200885A1 (en) | 2013-06-11 | 2014-12-18 | Janssen Pharmaceutica Nv | PDE10a INHIBITORS FOR THE TREATMENT OF TYPE II DIABETES |
| RS56034B1 (sr) | 2013-06-11 | 2017-09-29 | Bayer Pharma AG | Derivati prolekova supstituisanih triazolopiridina |
| US9193736B2 (en) | 2013-06-11 | 2015-11-24 | Janssen Pharmaceutica, Nv | PDE 10a inhibitors for the treatment of type II diabetes |
| TWI648272B (zh) | 2013-06-25 | 2019-01-21 | 美商必治妥美雅史谷比公司 | 經取代之四氫咔唑及咔唑甲醯胺化合物 |
| WO2014210087A1 (en) | 2013-06-25 | 2014-12-31 | Bristol-Myers Squibb Company | Carbazole carboxamide compounds useful as kinase inhibitors |
| US9453002B2 (en) | 2013-08-16 | 2016-09-27 | Janssen Pharmaceutica Nv | Substituted imidazoles as N-type calcium channel blockers |
| AR097543A1 (es) * | 2013-09-06 | 2016-03-23 | Lexicon Pharmaceuticals Inc | COMPUESTOS BASADOS EN IMIDAZO[1,2-b]PIRIDAZINA, COMPOSICIONES QUE LOS COMPRENDEN Y SUS MÉTODOS DE USO |
| EP3080131B1 (en) * | 2013-12-10 | 2018-10-10 | Bristol-Myers Squibb Company | Imidazopyridazine compounds useful as modulators of il-12, il-23 and/or ifn alpha responses |
| AU2014372638A1 (en) | 2013-12-23 | 2016-06-16 | Norgine B.V. | Compounds useful as CCR9 modulators |
| US10562897B2 (en) | 2014-01-16 | 2020-02-18 | Janssen Pharmaceutica Nv | Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators |
| TW201613927A (en) | 2014-09-01 | 2016-04-16 | Bayer Pharma AG | Method for preparation of substituted imidazopyridazines |
| EA034931B1 (ru) | 2014-10-24 | 2020-04-08 | Бристол-Майерс Сквибб Компани | Индолкарбоксамидные соединения |
| HUE061448T2 (hu) | 2014-11-16 | 2023-07-28 | Array Biopharma Inc | (S)-N-(5-((R)-2-(2,5-difluorofenil)-pirrolidin-1-il)-pirazolo[1,5-A]pirimidin-3-il) -3-hidroxipirrolidin-1-karboxamid-hidrogénszulfát kristályos formája |
| KR101635173B1 (ko) | 2014-12-03 | 2016-06-30 | 충남직물공업협동조합 | 디지털프린팅 날염 친환경 자카드직물의 제조방법 및 그 직물 |
| MA41174B1 (fr) | 2014-12-19 | 2019-09-30 | Janssen Pharmaceutica Nv | Dérivés d'imidazopyridazine utilisés en tant qu'inhibiteurs de pi3kbeta |
| AU2015366202B2 (en) | 2014-12-19 | 2020-01-02 | Janssen Pharmaceutica Nv | Heterocyclyl linked imidazopyridazine derivatives as PI3Kbeta inhibitors |
| CN107530329B (zh) | 2015-03-09 | 2021-10-08 | 奥瑞基尼探索技术有限公司 | 用作CDK抑制剂的吡唑并[1，5-a][1，3，5]三嗪和吡唑并[1，5-a]嘧啶衍生物 |
| EP3365340B1 (en) | 2015-10-19 | 2022-08-10 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| CN108697708A (zh) | 2015-10-26 | 2018-10-23 | 洛克索肿瘤学股份有限公司 | Trk抑制剂抗性癌症中的点突变以及与此相关的方法 |
| US20170145025A1 (en) | 2015-11-19 | 2017-05-25 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| ES2916874T3 (es) | 2015-12-17 | 2022-07-06 | Incyte Corp | Derivados de N-fenil-piridina-2-carboxamida y su uso como moduladores de la interacción proteína/proteína PD-1/PD-L1 |
| AU2016379372A1 (en) | 2015-12-22 | 2018-08-02 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| US10045991B2 (en) | 2016-04-04 | 2018-08-14 | Loxo Oncology, Inc. | Methods of treating pediatric cancers |
| ES2987474T3 (es) | 2016-04-04 | 2024-11-15 | Loxo Oncology Inc | Formulaciones líquidas de (S)-N-(5-((R)-2-(2,5-difluorofenil)-pirrolidin-1-IL)-pirazolo[1,5-A]pirimidin-3-IL)-3-hidroxipirrolidina-1-carboxamida |
| ES2906460T3 (es) | 2016-05-06 | 2022-04-18 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| ES2836222T3 (es) | 2016-05-18 | 2021-06-24 | Loxo Oncology Inc | Preparación de (S)-N-(5-((R)-2-(2,5-difluorofenil)pirrolidin-1-il)pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidina-1-carboxamida |
| ES2905980T3 (es) | 2016-05-26 | 2022-04-12 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| CN109563095B (zh) * | 2016-06-02 | 2021-10-29 | 细胞基因公司 | 动物和人抗疟剂 |
| BR112018076534A2 (pt) | 2016-06-20 | 2019-04-02 | Incyte Corporation | compostos heterocíclicos como imunomoduladores |
| MA45669A (fr) | 2016-07-14 | 2019-05-22 | Incyte Corp | Composés hétérocycliques utilisés comme immunomodulateurs |
| ES2941716T3 (es) | 2016-08-29 | 2023-05-25 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| JOP20190092A1 (ar) | 2016-10-26 | 2019-04-25 | Array Biopharma Inc | عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها |
| EP3541817B1 (en) * | 2016-11-17 | 2020-12-23 | Bristol-Myers Squibb Company | Imidazopyridazine modulators of il-12, il-23 and/or ifn-alpha |
| ES2952744T3 (es) | 2016-12-15 | 2023-11-03 | Nestle Sa | Composiciones y procedimientos que modulan los glóbulos blancos o los neutrófilos en un animal de compañía |
| ES2874756T3 (es) | 2016-12-22 | 2021-11-05 | Incyte Corp | Derivados de triazolo[1,5-A]piridina como inmunomoduladores |
| AU2017382870B2 (en) | 2016-12-22 | 2022-03-24 | Incyte Corporation | Benzooxazole derivatives as immunomodulators |
| WO2018119286A1 (en) | 2016-12-22 | 2018-06-28 | Incyte Corporation | Bicyclic heteroaromatic compounds as immunomodulators |
| ES2899402T3 (es) | 2016-12-22 | 2022-03-11 | Incyte Corp | Derivados de piridina como inmunomoduladores |
| JOP20190213A1 (ar) | 2017-03-16 | 2019-09-16 | Array Biopharma Inc | مركبات حلقية ضخمة كمثبطات لكيناز ros1 |
| DK3606926T3 (da) | 2017-04-05 | 2021-07-05 | Curovir Ab | Heteroaromatiske forbindelser anvendelige i terapi |
| WO2018195397A2 (en) * | 2017-04-21 | 2018-10-25 | Kyn Therapeutics | Indole ahr inhibitors and uses thereof |
| KR102717819B1 (ko) * | 2017-07-28 | 2024-10-14 | 다케다 야쿠힌 고교 가부시키가이샤 | Tyk2 억제제 및 이의 용도 |
| EP3768681A4 (en) * | 2018-03-01 | 2022-02-09 | The Johns Hopkins University | INHIBITION OF nSMase FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION |
| CR20200520A (es) | 2018-03-30 | 2021-03-09 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| WO2019217821A1 (en) | 2018-05-11 | 2019-11-14 | Incyte Corporation | Tetrahydro-imidazo[4,5-c]pyridine derivatives as pd-l1 immunomodulators |
| EP3829719B1 (en) * | 2018-07-27 | 2025-04-02 | Cocrystal Pharma, Inc. | Pyrrolo[2,3-b]pyridin derivatives as inhibitors of influenza virus replication |
| CN120865208A (zh) * | 2019-01-23 | 2025-10-31 | 武田药品工业株式会社 | Tyk2抑制剂和其用途 |
| CN114222744B (zh) * | 2019-03-05 | 2024-06-25 | 百时美施贵宝公司 | 可用作IL-12、IL-23和/或IFNα反应调节剂的咪唑并哒嗪化合物 |
| EP3969442A4 (en) * | 2019-05-17 | 2023-08-02 | Kinnate Biopharma Inc. | FIBROBLAST GROWTH FACTOR RECEPTOR KINASE INHIBITORS |
| EP4010342A1 (en) | 2019-08-09 | 2022-06-15 | Incyte Corporation | Salts of a pd-1/pd-l1 inhibitor |
| WO2021067217A1 (en) | 2019-09-30 | 2021-04-08 | Incyte Corporation | Pyrido[3,2-d]pyrimidine compounds as immunomodulators |
| BR112022009031A2 (pt) | 2019-11-11 | 2022-10-11 | Incyte Corp | Sais e formas cristalinas de um inibidor de pd-1/pd-l1 |
| IL298760A (en) | 2020-06-05 | 2023-02-01 | Kinnate Biopharma Inc | Fibroblast growth factor receptor kinase inhibitors |
| US11780836B2 (en) | 2020-11-06 | 2023-10-10 | Incyte Corporation | Process of preparing a PD-1/PD-L1 inhibitor |
| US11866434B2 (en) | 2020-11-06 | 2024-01-09 | Incyte Corporation | Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof |
| WO2022099075A1 (en) | 2020-11-06 | 2022-05-12 | Incyte Corporation | Crystalline form of a pd-1/pd-l1 inhibitor |
| US20240293386A1 (en) * | 2021-06-22 | 2024-09-05 | Lg Chem, Ltd. | Novel compound as protein kinase inhibitor |
| EP4268824A1 (en) * | 2022-04-26 | 2023-11-01 | Manros Therapeutics | Imidazo[2,1-f][1,2,4]triazine derivatives useful as a medicament |
| WO2025199211A1 (en) * | 2024-03-19 | 2025-09-25 | Yale University | Imidazopyridines and imidazopyrimidines, and methods of using same |
| WO2025199359A1 (en) * | 2024-03-21 | 2025-09-25 | The Translational Genomics Research Institute | Methods of modulating cdk7 and flt3 using fused bicyclic compounds |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166851A (en) | 1977-05-16 | 1979-09-04 | Merck & Co., Inc. | Certain imidazo(1,2a)pyridine derivatives |
| CH635587A5 (fr) * | 1978-01-09 | 1983-04-15 | Aron Sa | Derives amines de pyrazolo (1,5-a) s.triazine, therapeutiquement actifs et leurs procedes de preparation. |
| FR2619818B1 (fr) * | 1987-09-01 | 1990-01-12 | Sanofi Sa | Imidazo (1,2-b) pyridazines, procede pour leur preparation et compositions pharmaceutiques les contenant |
| US5260285A (en) | 1990-12-07 | 1993-11-09 | Merck & Co., Inc. | Substituted imidazopyridazines as angiotensin II antagonists |
| DE4327027A1 (de) | 1993-02-15 | 1994-08-18 | Bayer Ag | Imidazoazine |
| IL127566A0 (en) | 1996-08-28 | 1999-10-28 | Pfizer | Substituted 6,5-hetero- bicyclic derivatives |
| EP1345941A1 (fr) * | 2000-12-20 | 2003-09-24 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Inhibiteurs de kinases dependantes des cylines (cdk) et de la glycogene synthase kinase-3 (gsk-3) |
| FR2850653A1 (fr) * | 2003-02-04 | 2004-08-06 | Univ Pasteur | Derives de pyrazolotriazine, procede de preparation et utilisations |
| JP4564485B2 (ja) * | 2003-02-28 | 2010-10-20 | 帝人ファーマ株式会社 | ピラゾロ［１，５−ａ］ピリミジン誘導体 |
| DE10356579A1 (de) * | 2003-12-04 | 2005-07-07 | Merck Patent Gmbh | Aminderivate |
| PE20051128A1 (es) | 2004-02-25 | 2006-01-16 | Schering Corp | Pirazolotriazinas como inhibidores de quinasa |
| US7537840B2 (en) * | 2004-08-05 | 2009-05-26 | H.B. Licensing & Financing, Inc. | Polyamide adhesive and articles including the same |
| WO2006107784A1 (en) * | 2005-04-05 | 2006-10-12 | Eli Lilly And Company | Imidazopyridazine compounds |
-
2006
- 2006-09-21 US US11/524,996 patent/US20070078136A1/en not_active Abandoned
- 2006-09-22 PE PE2006001149A patent/PE20070520A1/es active IP Right Grant
- 2006-09-22 KR KR1020087009516A patent/KR101399766B1/ko not_active Expired - Fee Related
- 2006-09-22 SI SI200631578T patent/SI1928879T1/sl unknown
- 2006-09-22 EA EA200800873A patent/EA017632B1/ru not_active IP Right Cessation
- 2006-09-22 NZ NZ566663A patent/NZ566663A/en not_active IP Right Cessation
- 2006-09-22 EP EP06825074A patent/EP1928879B1/en active Active
- 2006-09-22 WO PCT/US2006/037056 patent/WO2007038314A2/en not_active Ceased
- 2006-09-22 TW TW102124973A patent/TWI478925B/zh not_active IP Right Cessation
- 2006-09-22 HR HRP20130155TT patent/HRP20130155T1/hr unknown
- 2006-09-22 BR BRPI0616393A patent/BRPI0616393B8/pt not_active IP Right Cessation
- 2006-09-22 TW TW095135141A patent/TWI441825B/zh not_active IP Right Cessation
- 2006-09-22 KR KR1020147007661A patent/KR20140058645A/ko not_active Withdrawn
- 2006-09-22 CA CA2623369A patent/CA2623369C/en active Active
- 2006-09-22 ES ES06825074T patent/ES2402664T3/es active Active
- 2006-09-22 DK DK06825074.5T patent/DK1928879T3/da active
- 2006-09-22 PL PL06825074T patent/PL1928879T3/pl unknown
- 2006-09-22 GE GEAP200610649A patent/GEP20104943B/en unknown
- 2006-09-22 AU AU2006295439A patent/AU2006295439B2/en not_active Ceased
- 2006-09-22 JP JP2008532430A patent/JP5241498B2/ja not_active Expired - Fee Related
- 2006-09-22 PT PT68250745T patent/PT1928879E/pt unknown
- 2006-09-25 AR ARP060104153A patent/AR055177A1/es active IP Right Grant
-
2008
- 2008-03-10 NO NO20081231A patent/NO20081231L/no not_active Application Discontinuation
- 2008-03-18 IL IL190280A patent/IL190280A/en active IP Right Grant
-
2013
- 2013-05-09 CY CY20131100374T patent/CY1114001T1/el unknown
- 2013-06-21 PH PH12013501329A patent/PH12013501329B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009509961A5 (https=) | ||
| HRP20130155T1 (hr) | Fuzionirani heterocikliäśki spojevi korisni kao modulatori kinaze | |
| AU2019283921B2 (en) | Indole carboxamide compounds useful as kinase inhibitors | |
| JP2862375B2 (ja) | Ｃｒｆアンタゴニストとしてのピラゾロピリミジン | |
| JP6720355B2 (ja) | ヘテロアリール置換のアミノピリジン化合物 | |
| JP2020183410A5 (https=) | ||
| KR102345381B1 (ko) | 키나제 억제제로서 유용한 카르바졸 카르복스아미드 화합물 | |
| RU2004111979A (ru) | Производные 1н-имидазола, обладающие св1-агонистической, частичной св1-агонистической или св1-антагонистической активностью | |
| JP2005507380A5 (https=) | ||
| JP2020510010A5 (https=) | ||
| JP2013523889A5 (https=) | ||
| NZ592809A (en) | SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS | |
| JP2017533968A5 (https=) | ||
| JP2017535536A (ja) | カルバゾール誘導体 | |
| JP2019527724A5 (https=) | ||
| JP2003507479A5 (https=) | ||
| JP2025538490A (ja) | 疾患の処置のためのフタラジノン系調節剤 | |
| JP2022505827A (ja) | 置換インドール二量体の化合物 | |
| CN103025722B (zh) | 具有2-(杂芳基)氨基取代基的氯苯吩嗪及其抗微生物活性 | |
| JP2007520536A5 (https=) | ||
| CA2487948A1 (en) | Azole methylidene cyanide derivatives and their use as protein kinase modulators | |
| JP7756374B2 (ja) | ピリドピリミジン系化合物及びその使用 | |
| RU2022119586A (ru) | ЗАМЕЩЕННЫЕ ПИРАЗОЛО[1,5-a]ПИРИМИДИНОВЫЕ СОЕДИНЕНИЯ КАК ИНГИБИТОРЫ ТРК КИНАЗЫ | |
| RU2022101112A (ru) | Бициклические гетероциклические соединения в качестве ингибиторов активности bcdin3d |